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A beneficial host-microbe symbiosis that has been extensively studied is the association of
the Hawaiian bobtail squid, Euprymna scolopes, with the bioluminescent bacterium Vibrio fischeri
in the squid light organ. Our research used the Hawaiian bobtail squid as a model system to begin
investigating the functional role of secondary metabolites associated with the accessory nidamental
gland (ANG), a reproductive organ present in sexually mature female cephalopods, and jelly coat
(JC) bacteria. Using this model organism, prior research supports that bacteria from the ANG are
deposited into the egg JC. Subsequently, the JC bacteria produce compounds as a chemical defense
mechanism during their physically unprotected embryonic period. A suite of analytical chemistry
techniques (e.g. tandem mass spectrometry, direct analysis in real time mass spectrometry, liquid
chromatography mass spectrometry, nuclear magnetic resonance) has been utilized to perform
extensive chemical profiling of ANG and JC bacteria. In addition, ANG and JC bacterial extracts
tested in biological assays demonstrate potent inhibition against various pathogens including
Vibrio spp., Fusarium keratoplasticum, and Candida albicans. This research investigates chemical
defense mechanisms utilized within these symbiotic systems, including the influence of the host
environment on the production of chemical compounds by bacterial symbionts. We have shown
that the ANG and JC bacteria produce antimicrobial compounds, providing some insight into the
possible function of the ANG.
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Chapter I: Introduction

Natural products
Natural products continue to be an abundant source for structurally diverse compounds
originating from a variety of organisms including terrestrial and marine (Cragg and Newman,
2013). These compounds can be broadly classified into primary and secondary metabolites.
Primary metabolites (e.g. amino acids, nucleic acids, sugars) are vital for maturity, proliferation,
and reproduction of an organism. In contrast, secondary metabolites are considered not essential
for the normal development of an organism (Stanforth, 2006). Secondary metabolites provide
specialized survival benefits to the producing organism through a variety of mechanisms including
but not limited to, self-defense against competing organisms, increased fitness to harsh
environmental conditions, and inter-cellular communication (Demain and Fang, 2000).
Because of their biological role in the producing organism, secondary metabolites often
possess potent biological activity and the potential to be utilized for preclinical drug candidates
(Demain and Fang, 2000). Of the small molecule approved drugs from 1981 to 2014,
approximately 38% are derived from natural products, semi-synthetic natural product analogues,
or synthetic compounds based on natural product pharmacophores (Newman and Cragg, 2016). A
majority of known natural products have emanated from studies of terrestrial organisms, primarily
due to the ease of collecting large volumes of samples. (Adnani et al., 2017; Gerwick and Moore,
2012). However, since the development of the self-contained underwater breathing apparatus
(SCUBA) and remotely operated vehicles (ROV) technologies, researchers have been able to
explore portions of the marine environment that were previously inaccessible. This had led to
increased discovery of novel marine microorganisms that are capable of biosynthesizing diverse
natural products (Gerwick and Moore, 2012).
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Marine Natural Products
Due to the abundance of marine environments around the world, there is a large amount of
biodiversity that has not been fully exploited for drug discovery (Adnani et al., 2017; Donia and
Hamann, 2013). This niche represents a reservoir from which scientists can continue to expand the
chemical space through discovering and characterizing potent biologically active natural products
(Adnani et al., 2017). Marine organisms have evolved to survive under various environmental
stresses such as high salinity, low light, and increased pressure (Lindequist, 2016). Some of these
organisms are relatively sessile and soft-bodied (e.g. tunicates, sponges) and therefore they are
more vulnerable to predation and biofilm formation (Lindequist, 2016). To our benefit, intense
competition and unique stressors have provided evolutionary pressure for many of these marine
organisms to protect themselves through the production of defensive or functional secondary
metabolites.
One of the earliest marine metabolites was described from a marine sponge Tethya crypta
collected near the Florida coast (Bergmann and Feeney, 1951; Bergmann and Burke, 1956). This
class of compounds includes the unique nucleosides (spongothymidine and spongouridine) that
are composed of arabinose residues instead of deoxyribose or ribose units (Figure 1) (Bergmann
and Feeney, 1951; Bergmann and Burke, 1956). This discovery inspired the synthesis of two
derivatives cytarabine (Cytosar-U; Ara-C) and vidarabine (Vira-A; Ara-A) that were later
approved by the U.S. Food and Drug Administration (FDA) for the treatment of viral infections
and cancer, respectively (Figure 1) (Stonik, 2009).
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Figure 1. Arabino-nucleosides spongothymidine and spongouridine isolated from the marine
sponge Tethya crypta and their synthetic derivatives cytarabine and vidrabine.

After the arabino-nucelosides, ziconotide received FDA approval in 2004 for the treatment of
severe chronic pain (Figure 2). Ziconotide is a synthetic form of ω-MVIIA, a peptide with 25
amino acids and three disulfide bridges, originally isolated from the venom of Conus magus (cone
snail) and identified to be a selective and potent inhibitor of N-type voltage gated calcium channels
with minimal affinity to other calcium channel subtypes (McIntosh et al., 1982).

Figure 2. Amino acid sequence and disulfide bridging pattern of ziconotide.

In addition to the three aforementioned compounds, there have been two additional FDA
approved drugs incorporating marine derived compounds, eribulin mesylate (Halaven) and
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brentuximab vedotin (Adcetris). Eribulin mesylate is a synthetic analogue of halichondrin B that
was originally isolated from a marine sponge Lissodendoryx sp. (Bai et al., 1991), and brentuximab
vedotin is an antibody drug conjugate that integrates monomethyl auristatin E, a synthetic analogue
of dolstatin 10. Dolstatin 10 was originally isolated from the marine mollusc Dolabella auricularia
(Pettit et al., 1987; Luesch et al., 2001). Furthermore, the European Medicines Evaluation Agency
approved drug trabectedin was originally isolated from an ascidian Ecteinascidia turbinata and
shown to have strong anticancer activity (Figure 3) (Lichter et al., 1972; Ruiz-Torres et al., 2017).
These examples demonstrate the potential for marine organisms to produce structurally diverse
and biologically active metabolites.

Figure 3. Marine invertebrate U.S. Food and Drug Administration (FDA) and European
Medicines Evaluation Agency (EMEA) approved drugs.
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Symbiosis
Symbiotic relationships can be defined as close interactions between two or more
organisms (Adnani et al., 2017; Cleary et al., 2017; Lopanik et al., 2014). These relationships are
commonly established between eukaryotic hosts and microorganisms (Moya et al., 2009).
Symbioses are broadly categorized as mutualistic (both organisms benefit), commensalistic (one
organism benefits and the other organism remains unharmed), or parasitic (one organism benefits
and the other is harmed) (Dimijian, 2000). These relationships may be obligatory, meaning the
organisms depend on each other for survival, or facultative where each organism can live
independently (Adnani et al., 2017). Host-microbe symbioses have primarily been studied to
advance basic science by understanding unique and complex ecological systems (Flórez et al.,
2015). However, bacterial symbionts associated with host organisms are emerging as promising
sources for novel drug discovery because of the potential for bacterial symbionts to produce
defensive secondary metabolites (Flórez et al., 2015).

Invertebrate Microbial Symbioses
Terrestrial: Defensive symbioses have been investigated in terrestrial and marine hostmicrobe relationships where the bacterial symbiont produces secondary metabolites to either
inhibit harmful pathogens or ward off predators (Kaltenpoth et al., 2014). Symbiotic bacteria
associated with terrestrial invertebrates are known to protect the host’s nutritional resources by
producing antimicrobial compounds (Kaltenpoth et al., 2014). For example, fungus-growing ants
in the Attini tribe maintain a symbiotic relationship with a cultivar fungus, Leucoagaricus
gongylophorus (Cafaro et al., 2011; Zhang et al., 2007). In this relationship, the ants provide
nutrients to the cultivar fungus which serves as their primary nutritional source (Klassen, 2014).
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The cultivar fungus is susceptible to numerous pathogens including the parasitic fungus
Escovopsis. Therefore, various defense mechanisms have been adapted (Klassen, 2014; Currie et
al., 1999). The most well-known defense mechanism in this system is the production of secondary
metabolites by Pseudonocardia on the propleural plate of the ants to protect the cultivar fungus
(Cafaro et al., 2011). Pseudonocardia has been shown to produce antimicrobial compounds such
as dentigerumycin, a cyclic peptide, to protect the cultivar fungus against Escovopsis (Oh et al.,
2009).
In addition to the protection of nutritional resources, research has focused on the protection
of the terrestrial host from harmful microorganisms (Kaltenpoth et al., 2014). For example, female
beewolf digger wasps, Philanthus spp., have antennal glands that associate with an
actinobacterium Streptomyces philanthi (Kaltenpoth et al. 2014; Koehler et al., 2013; Kroiss et al.;
2010). This bacterial symbiont is applied to the brood cell ceiling and then integrated into the
cocoon subsequently producing antimicrobial compounds as a defense mechanism to protect the
larvae from pathogenic microorganisms (Koehler et al., 2013; Kroiss et al.; 2010). Further
investigation of S. philanthi determined the antimicrobial protection is primarily attributed to the
production of piericidin analogues and streptochlorin (Figure 4) (Kroiss et al., 2010). These
compounds are produced within the first two weeks of larval development, localized to the surface
of the cocoon, and are stable for extended periods of time most likely due to the dark and dry
climate within the cocoon surface limiting the exposure of the compounds to air, heat, light and
moisture (Koehler et al., 2013). The long-term stability of the antibiotics is important for the
protection of the beewolf during hibernation (Koehler et al., 2013) and may make for improved
pharmacokinetic properties as these are explored for drug discovery and development.
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Figure 4. Secondary metabolites produced by Streptomyces philanthi to protect the
Philanthus spp. larvae.

Marine: Marine organisms are known to be prolific producers of secondary metabolites
with potent biological activity (Newman and Cragg, 2004). In the ocean, marine invertebrates
often establish symbiotic relationships with microbes due to their constant interaction of
microorganisms from the seawater by filter feeding (Apprill, 2017; Lopanik, 2014). Sessile marine
invertebrate organisms (e.g., mollusks, sponges, tunicates) and their associated microbial
symbionts are a prime source for defensive secondary metabolites because these organisms lack
or have limited mobility and therefore may rely upon structurally diverse and biologically active
compounds to defend themselves (Schmidt et al. 2012; Schmidt et al., 2008).
Numerous biologically active natural products have been isolated from sessile marine
invertebrate organisms, although the true producers of these biologically active secondary
metabolites are likely symbiotic microorganisms associated with these marine invertebrates
(Morita and Schmidt, 2018; Kobayashi and Ishibashi, 1993). One example is dolstatin 10 that was
originally isolated from the mollusc Dolabella auricularia (Figure 5) (Pettit et al., 1987). Dolstatin
8

10 is a modified linear peptide composed of five amino acid-like residues and was found to possess
potent antitumor activity against NCI human melanoma, B16 melanoma, and PS leukemia in
xenograph mouse models (Luesch et al., 2001), Dolstatin 10 was found to be produced by a species
of the marine cyanobacterium, Symploca sp., that is consumed by the mollusc D. auricularia
(Luesch et al., 2002). Another example is dysidenin, a highly chlorinated peptide derivative,
initially isolated from the sponge Dysidea herbacea (Figure 5) (Kazlauskas et al., 1977), but
further investigation using cell separation, fluorescence in situ hybridization, and genetic probes
identified Oscillatoria spongeliae, cyanobacterial symbiont, as the producer of these compounds
(Flatt et al., 2005).
There is also a symbiotic relationship between the bryozoan Bulga neritina and the
gammaproteobacterial symbiont Candidatus Endobugula seratula (Haygood and Davidson,
1997). The bryostatins are macrocyclic polyketides that were originally isolated from B. neritina
(Figure 5) (Pettit et al., 1982). These compounds are protein kinase C modulators and found to
deter fish from preying on larvae (Lopanik et al., 2004). Because the bryostatins were structurally
similar to bacterial secondary metabolites, the origin of these compounds was hypothesized to
come from E. seratula. After discovering a bryostatin biosynthetic gene cluster in E. seratula the
bacterium was determined to be the most likely the source of the bryostatins (Hildebrand et al.
2004, Sudek et al., 2007).
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Figure 5. Select examples of secondary metabolites associated with sessile marine
invertebrates.

In mobile marine invertebrate organisms (e.g., shrimp, squid) microbial symbionts may
also produce secondary metabolites for defense, but have typically been related to protection of
eggs or larval stages. One of the earliest examples of symbiont mediated chemical defense was
highlighted in crustaceans. In Palaemon macrodactylus (caridean shrimp) an epibiotic Altermonas
sp. bacterium was consistently isolated from the surface of larvae and subsequently shown to
produce 2,3-indolinedione (isatin) (Figure 6) (Gil-Turnes et al., 1989). After the larvae were
treated with antibiotics to eliminate bacterial symbionts, they were reinoculated with
either Altermonas sp. culture or isatin. The results suggested both the Altermonas sp. culture and
isatin improved embryo survival and reduced colonization of Lagenidium callinectes, a marine
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fungal pathogen frequently associated with crustaceans (Gil-Turnes et al., 1989). A similar study
isolated an unidentified Gram-negative bacterium from the embryos of Homarus americanus
(American lobster) that was found to produce 4-hydroxyphenethyl alcohol (tyrosol) (Figure 6).
This compound also demonstrated inhibition of L. callinectes (Gil-Turnes and Fenical, 1992). A
similar chemical defense mechanism is hypothesized to occur with marine organisms that deposit
egg clutches.

Figure 6. Antifungal secondary metabolites produced by bacterial symbionts associated with
crustaceans.

Cephalopods such as the Hawaiian bobtail squid are known to deposit egg clutches on
benthic substrates in the ocean (Kerwin and Nyholm, 2018; Lee et al., 2009). The eggs and larvae
of marine organisms are exposed to numerous microorganisms in the ocean (Goeke et al., 2010).
In this competitive environment, cephalopod egg clutches should be vulnerable to fouling and
biofilm formation due to lack of parental care. Despite this, these eggs are resistant to fouling and
biofilm formation during their embryonic development period which can range from several weeks
to months (Benkendorff et al., 2001; Montgomery and McFall-Ngai, 1993; Fields, 1965).
Therefore, these eggs must rely on mechanisms for protection to ensure successful development
(Fields, 1965).
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Hawaiian bobtail squid
One of the most well-studied marine host-microbe relationships is the binary symbiosis of
the Hawaiian bobtail squid, Euprymna scolopes, with the bioluminescent bacterium Vibrio fischeri
in the squid light organ (Nyholm and McFall-Ngai, 2004; McFall-Ngai, 2002; McFall-Ngai and
Ruby, 1991). In this symbiosis, V. fischeri protect the nocturnal host from predation using
counterillumination to mimic the moonlight conditions while the squid forage for food (Jones and
Nishiguchi, 2004). After V. fischeri colonize in the light organ the ciliated appendages around the
light organ undergo apoptosis initiated by lipopolysaccharide and peptidoglycan (Nyholm and
McFall-Ngai, 2004). Throughout the day the bacterial concentration of V. fischeri increases within
the light organ (Nyholm and McFall-Ngai, 2004). At night the increased cell population induces
the transcription of luciferase causing the luminescence (Lupp and Ruby, 2005). In the morning,
the squid vents approximately 95% of V. fischeri into the surrounding seawater to maintain a stable
population for juveniles (Nyholm and McFall-Ngai, 1998). The Hawaiian bobtail squid is a
tractable experimental model to study the chemical defense mechanisms utilized within this
symbiotic system because there is a single bacterial symbiont associated with the host, both
partners can be cultured independently, and V. fischeri can be genetically manipulated to study the
colonization of this bacteria within the light organ (McFall-Ngai, 2014).
In addition to the light organ, these organisms have an accessory nidamental gland (ANG)
(Figure 7A-B) (Collins et al., 2015; Collins et al., 2012). The ANG is a reproductive organ present
in many sexually mature female species of squid and cuttlefish (Kerwin and Nyholm, 2018;
Kerwin and Nyholm, 2017; Collins et al., 2015; Collins et al., 2012). Within the ANG are
pigmented epithelium lined tubules with a microvilli brush border (Figure 7C) (Collins et al., 2015;
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Collins et al., 2012; Bloodgood, 1977). These tubules are composed of dense bacterial populations
that each contain a distinct bacterial taxon (Figure 7D) (Collins et al., 2015; Collins et al., 2012).

Figure 7. Relationship of the nidamental gland (NG), accessory nidamental gland (ANG),
light organ (LO), and jelly coat (JC) with squid eggs. (A) This image is a ventral dissection of
the Hawaiian bobtail squid representing the position of the NG, ANG, and LO that harbors the
bioluminescent bacterium V. fischeri (Collins et al., 2012). (B) An enlarged diagram of the NG
and ANG. (C) The epithelium lined tubules composed of dense bacterial communities within the
ANG. (D) Pigmented bacterial isolated from the ANG. Transmission electron microscopy image
of the cross section of the jelly coat and egg clutch image courtesy of Drs. Allison Kerwin and
Spencer Nyholm.
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The bacterial community of E. scolopes ANG was found to be dominated by
Alphaproteobacteria that is similar to the ANG bacterial communities associated with other
cephalopod species (Collins et al., 2012; Pichon et al., 2005; Grigioni et al., 2000). Further
investigation determined a majority of the ANG bacteria are from the Roseobacter clade within
Alphaproteobacteria (Collins et al., 2015; Collins et al., 2012). More specifically, Leisingera
(previously classified as Phaeobacter) has been identified as the dominant genus in the ANG
(Collins et al., 2015; Collins et al., 2012). In addition to Alphaproteobacteria, the ANG of E.
scolopes was comprised of Rhizobiales, Verrucomicrobia, and Flavobacteria (Collins et al., 2015;
Collins et al., 2012). Interestingly, the ANG bacterial community in E. scolopes is different from
other cephalopods due to the presence of Verrucomicrobia and lack of Gammaproetobacteria
(Kerwin and Nyholm, 2018; Kerwin and Nyholm, 2017; Collins et al., 2012).
Although Proteobacteria are underexplored for secondary metabolites (Machado et al.,
2015), some species from the Roseobacter clade are known to produce antimicrobial compounds
such as tropodithetic acid, roseobacticides, and indigoidine (Figure 8) (Seyedsayamdost et al.,
2011; Cude et al., 2012; Geng et al; 2008; Bruhn et al. 2005). Tropodithetic acid is known to inhibit
the growth of Vibrio anguillarum on fish larvae (Geng et al; 2008; Bruhn et al., 2005).
Roseobacticides demonstrate potent selective algaecidal activity against Emiliania huxleyi and
Rhodomonas salina (Seyedsayamdost et al., 2011). Indigoidine has been shown to reduce
colonization of V. fischeri (Cude et al., 2012).
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Figure 8. Antimicrobial secondary metabolites produced by bacteria within the Roseobacter
clade.

The ANG is located in close proximity to the nidamental gland and posterior to the light
organ that contains the bioluminescent bacterium V. fischeri (Figure 7B) (Collins et al., 2012;
Kaufman et al., 1998; Bloodgood, 1977). While previous research has established that the
nidamental gland (NG) of E. scolopes is responsible for producing the jelly coat (JC) that surrounds
squid eggs (Atkinson, 1973), the function of the ANG and associated bacteria remains elusive.
One proposed hypothesis is that the bacteria from the ANG are added into the JC (Kaufman et al.,
1998; Collins et al., 2012) and produce antimicrobial compounds to defend the eggs from fouling
and predators during their physically unprotected embryonic period (Biggs and Epel, 1991).
Additional studies have investigated the ANG for antimicrobial properties. One of the
earliest studies tested butanol extracts of the ANG and jelly coat from L. pealei against several
bacterial and fungal pathogens (Barbieri et al., 1997). The ANG extract demonstrated antibacterial
activity against Vibrio anguillarum, Aeromonas salmonicida, and Streptomyces griseus (Barbieri
et al., 1997). However, the jelly coat extract did not inhibit any pathogens (Barbieri et al., 1997).
In another study, butanol extracts were prepared from the ANG of L. duvuceli at three different
maturity stages (immature, ripe, and spent) and tested for antibacterial activity (Gomathi et al.,
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2010). After evaluating the three extracts, only the ripe ANG extract was able to inhibit E. coli, P.
aeruginosa, and S. aureus (Gomathi et al., 2010). Further analyses revealed the ripe extract
consisted of increased concentrations of unsaturated fatty acids that may contribute to the
biological activity (Gomathi et al., 2010). In a similar study, organic extracts from the ANG of
Sepioteuthis lessoniana at four different maturity stages (immature, maturing, ripe, and spent) were
tested for antibacterial activity (Venkatesan et al., 2014). The ripe ANG extracts exhibited the
strongest activity against E. coli, A. hydrophila, S. aureus, and B. megaterium, while the immature
ANG extracts had no antibacterial activity (Venkatesan et al., 2014). Although these studies
suggest the ANG has antimicrobial properties, there is lack of evidence that the defensive function
is due to the production of secondary metabolites by bacterial symbionts.

Research Objectives
Currently, the function of the ANG in the Hawaiian bobtail squid and the associated
bacteria remains elusive. While research has suggested that ANG-associated bacteria are deposited
into the egg JC and can produce defensive secondary metabolites, there has not been experimental
proof of this function or any isolation or identification of metabolites from the ANG or JC bacteria.
The overall goal of this research project is to identify biologically active compounds associated
with the ANG and utilize comparative metabolomics to investigate secondary metabolite profiles
of bacteria isolated from the ANG and JC. In this research project, three separate experimental
sections are included: (1) Leisingera sp. JC1, a bacterial isolate from the Hawaiian bobtail squid
eggs, produces indigoidine and differentially inhibits vibrios, (2) bacteria associated with the
Hawaiian bobtail squid protect eggs from fungal fouling, and (3) chemical networking analyses to
identify secondary metabolites from Labrenzia sp. ANG18, a bacterial symbiont.
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1. Leisingera sp. JC1, a bacterial isolate from the Hawaiian bobtail squid eggs, produces
indigoidine and differentially inhibits vibrios
In this chapter, a jelly coat bacterium, Leisingera sp. JC1, will be investigated for its ability
to produce antimicrobial compounds due to similar pigmentation and colony morphology to
Leisingera sp. Y4I, a strain known to biosynthesize the antibiotic, indigoidine. Mass spectrometry
will be used to investigate the production of indigoidine by JC1 and the genome of Leisingera sp.
JC1 will be analyzed for known biosynthetic gene clusters. Furthermore, the regulation of
indigoidine will be investigated through co-culture experiments with marine pathogens to explore
the role of indigoidine in this host-microbe system.

2. Bacteria associated with the Hawaiian bobtail squid protect eggs from fungal fouling
In this chapter, in vivo experiments with egg clutches will be performed to determine if the
JC bacterial community protects the eggs from fungal fouling. ANG and JC bacterial extracts will
be evaluated for antifungal activity through in vitro biological assays against filamentous and yeast
fungal pathogens. Lastly, comparative metabolomics will be used to identify defensive secondary
metabolites that may be used to protect the eggs from fungal fouling.

3. Chemical networking analyses reveals secondary metabolites from Labrenzia sp. ANG18, a
bacterial symbiont
In this chapter, Labrenzia sp. ANG18, an accessory nidamental gland bacterial isolate, will
be tested for antifungal activity against three phylogenetically related Fusarium keratoplasticum
strains and C. albicans. In addition, the Labrenzia sp. ANG18 genome will be analyzed via
analysis of the genome with antibiotic and secondary metabolite shell (antiSMASH) (Weber et al.,
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2015) to identify known biosynthetic gene clusters. Lastly, a suite of mass spectroscopic and
nuclear magnetic resonance techniques will be used to isolate and identify biologically active
constituents of Labrenzia sp. ANG18.
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Chapter II: Leisingera sp. JC1, a Bacterial Isolate from Hawaiian Bobtail Squid Eggs,
Produces Indigoidine and Differentially Inhibits Vibrios

Significant Contributions
Significant contributions to this chapter were made by the following researchers: Drs.
Andrea Suria and Spencer Nyholm, University of Connecticut, isolated Leisingera sp. JC1 used
for culture and extraction, analyzed the genome, and generated the zone of inhibition data for
Figure 11. Portions of this chapter have been previously published as: Gromek. S.M.; Suria, A.;
Fullmer, M.S.; Garcia, J.L.; Gogarten, J.P.; Nyholm, S.V.; Balunas, M.J. Leisingera sp. JC1, a
bacterial isolate from Hawaiian bobtail squid eggs, produces indigoidine and differentially inhibits
vibrios. Front. Microbiol., 2016, 7,1342.
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Introduction
Marine host-microbe assemblages are emerging as a promising source of lead compounds
for drug discovery due to the production of biologically active compounds as a chemical defense
mechanism (Simmons et al., 2008). Some bacterial symbionts associated with marine invertebrates
(e.g. bryozoans, soft corals, tunicates, and molluscs) have been shown to produce compounds to
protect the host from fouling and predators (Morita and Schmidt, 2018; Flórez et al., 2015).
Because the host is constantly exposed to microorganisms, the host may select microbes and coevolve with these microbial symbionts to produce compounds that benefit the host (Lopanik,
2014). However, there is still difficulty understanding the functional role of compounds within
symbiotic relationships because of the complex interactions among the host, microbial symbionts,
environmental pathogens, and/or predators (Morita and Schmidt, 2018).
One well-studied marine host-microbe relationship is the interaction of the Hawaiian
bobtail squid, Euprymna scolopes, with the bioluminescent bacterium Vibrio fischeri in the squid
light organ (Nyholm and McFall-Ngai, 2004; McFall-Ngai, 2002; McFall-Ngai and Ruby, 1991).
In addition to the light organ, these cephalopods have an accessory nidamental gland (ANG) found
in sexually mature females (Collins et al., 2012). The ANG is composed of pigmented epithelium
lined tubules that each contain distinct bacterial taxon (Collins et al., 2012). Numerous bacterial
taxa are found within the ANG, however Alphaproteobacteria, Gammaproteobacteria, and
Verrucomicrobia, are dominant (Kerwin and Nyholm, 2017; Collins et al., 2015; Collins et al.,
2012). The majority of ANG bacteria are from the Roseobacter clade of Alphaproteobacteria.
There are several examples of species from the Roseobacter clade producing antimicrobial
compounds, such as Phaeobacter species producing tropodithietic acid (TDA) (Berger et al., 2011;
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Geng et al., 2008) and Leisingera sp. Y4I (formerly Phaeobacter) producing indigoidine (Cude et
al., 2012).
While previous research has determined that the nidamental gland (NG) of E. scolopes is
responsible for producing the jelly coat (JC) that surrounds squid eggs, the function of the ANG
and associated bacteria remains unproven (Collins et al., 2015; Collins et al., 2012; Bloodgood,
1977). One proposed hypothesis is the ANG works in conjunction with the NG to secrete bacteria
in the egg JC, and the bacteria produce biologically active secondary metabolites as a chemical
defense mechanism to protect the physically unprotected eggs against pathogenic microorganisms
and predators (Kerwin and Nyholm, 2017; Collins et al., 2012; Biggs and Epel, 1991). The
potential for ANG bacteria to produce secondary metabolites was supported by genomic analysis
revealing several biosynthetic gene clusters including polyketide/non-ribosomal peptide
synthases, terpenes, and bacteriocins (Collins et al., 2015).
In this chapter, a jelly coat bacterium isolated from squid eggs, Leisingera sp. JC1, was
investigated for the production of antimicrobial compounds due to the similar pigmentation and
colony morphology as Leisingera sp. Y4I strain known to biosynthesize the antibacterial
compound, indigoidine. LC-MS was used to identify the production of indigoidine by Leisingera
sp. JC1 and DART-MS was used to investigate the possible localization of indigoidine to the outer
edges of the Leisingera sp. JC1 bacterial colonies in the presence of V. fischeri, the light organ
bacterial symbiont. In addition, Leisingera sp. JC1 and bacterial extracts were evaluated using in
vitro biological assays for the ability to inhibit marine vibrios. Lastly, the regulation of indigoidine
biosynthesis was investigated via co-culture experiments with vibrio strains to evaluate whether
indigoidine may be a defensive metabolite associated with the Hawaiian bobtail squid.
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Results and Discussion
Detection of Indigoidine Production by Leisingera sp. JC1
In a previous study, Leisingera sp. Y4I strain was found to produce indigoidine, a
secondary metabolite shown to reduce surface colonization and growth of V. fischeri (Cude et al.,
2012). Due to similar colony morphology and pigmentation as the Y4I strain, a bacterium isolated
from the jelly coat (JC) of squid eggs, Leisingera sp. JC1, was investigated for indigoidine
production. Leisingera sp. JC1 was cultured using a three-step process to promote secondary
metabolite production during the late growth phase of the bacterium resulting in a deep blue liquid
culture possibly indicative of indigoidine (Ruiz et al., 2010). Because indigoidine is known to be
insoluble in most organic solvents (Novakova et al., 2010), a resin-based extraction protocol
afforded minimal quantities of indigoidine integrating to 0.8% in the extract as determined via
liquid chromatography mass spectrometry analysis (LC-MS) (Figure 9D and 9E). To more
efficiently extract indigoidine from cultures, a centrifugation method (Yu et al., 2013) was
employed to separate indigoidine from media and cellular components. After centrifugation, the
indigoidine-enriched pellet was dissolved in dimethyl sulfoxide (DMSO) yielding an indigoidine
enriched extract with greater quantities of indigoidine (91.1%). (Figure 9D) (Yu et al., 2013).
The indigoidine enriched extract was analyzed via LC-MS to confirm the production of
indigoidine (Figure 9A-C) with [M-H]- of 247.0 eluting at 10.7 minutes, consistent with the
molecular weight (248.2 g/mol), molecular formula C10H9N404, and fragmentation pattern from
previous literature (Yu et al., 2013; Cude et al., 2012). Indigoidine was originally identified in
Pseudomonas indigofera (Elazari-Volcani, 1939) and also detected in Streptomyces species
(actinobacteria) and Alpha-, Beta-, and Gammaproteobacteria (Cude et al., 2012; Takahashi et al.,
200; Reverchon et al., 2002). Indigoidine is a bicyclic 3,3'-bipyridyl compound synthesized by a
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non-ribosomal polyketide synthase through the condensation of two glutamine molecules (Cude
et al., 2015; Cude et al. 2012). Furthermore, indigoidine can be reduced to a colorless form,
leucoindigoidine (Cude et al., 2012; Heumann et al., 1968). Subsequent exposure of
leucoindigoidine to atmospheric oxygen is hypothesized to spontaneously oxidize the reduced
form to indigoidine (Cude et al., 2012; Heumann et al., 1968).
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Figure 9. Chemical analysis of indigoidine production by Leisingera sp. JC1 and
quantification of indigoidine in the normal and indigoidine enriched extract. (A) Structure of
indigoidine. (B) Extracted ion chromatogram (EIC) of ([M-H]- 247) to confirm the production of
indigoidine (248.19 g/mol) by Leisingera sp. JC1. (C) Negative ionization mass spectrum of the
peak at 10.7 min. The [M-H]- peak of 247.0 is consistent with a molecular formula of C10H9N404,
confirming the presence of indigoidine (248.19 g/mol) (Yu et al. 2013). (D) The normal extract
(blue) and indigoidine enriched extract (red) were monitored via LC-MS at UV 299 nm using an
isocratic method. The quantity of indigoidine, eluting at tR 8.2 mins, was measured in both extracts
using the area under the curve resulting in greater amounts of indigoidine found in the indigoidine
enriched extract (91.1%) and minimal amounts (0.8%) of indigoidine present in the normal extract.
(E) Negative ionization mass spectrum of the normal extract at tR 8.2 minutes. Although there is
an ion [M-H]- 247.2 in the normal extract, there are several additional ions in greater relative
abundance and minimal traces of indigoidine observed in D.
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Antibacterial Activity of Leisingera sp. JC1
Leisingera sp. JC1 was cultured in large scale and extracted using either the indigoidineenriched or normal extraction method to determine if indigoidine was responsible for the
antibacterial activity. Both extracts were initially tested at 500 µg/mL in a 96-well liquid assay
against the squid light organ bacterial symbiont, V. fischeri ES114, and two common marine
pathogens V. anguillarum 775 and V. parahaemolyticus KNH1 (Figure 10). The normal extract
demonstrated potent inhibition against V. fischeri with a percent control activity (PCA) value of
17.9 ± 9.3 whereas the indigoidine-enriched extract exhibited moderate inhibition against V.
fischeri with a PCA value of 63.3 ±6.7. There was no inhibition observed by either extract against
V. anguillarum or V. parahaemolyticus.
Previous studies with Leisingera sp. Y4I suggest a direct correlation between the
production of indigoidine and inhibition of V. fischeri, with hyperpigmented mutant strains of Y4I
demonstrating stronger antimicrobial activity (Cude et al., 2012). Although the indigoidineenriched extract reduced the growth of V. fischeri, the normal extract had more potent activity with
trace amounts of indigoidine present, potentially due to the presence of additional secondary
metabolites. Whole genome sequencing of Leisingera sp. JC1 (Appendix Figure A1) and analysis
using the antibiotics and Secondary Metabolite Analysis Shell (antiSMASH) (Weber et al., 2015)
revealed several secondary metabolite biosynthetic gene clusters including indigoidine,
siderophore, bacteriocin, and homoserine lactone clusters. These results indicate indigoidine may
not be solely responsible for the biological activity. While some bacteria within the roseobacter
clade are known to produce the antimicrobial compound TDA (Berger et al., 2011; Geng et al.,
2008), to date none of our ANG and JC genomes that have been sequenced possess the biosynthetic
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genes for this compound (Gromek et al., 2016; Collins et al., 2015) and TDA has not been detected
in any of the ANG and JC bacterial extracts analyzed via LC-MS (data not shown).
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Figure 10. Leisingera sp. JC1 extracts demonstrate differential activity against marine
vibrios in a 96-well liquid assay. The indigoidine (igi) enriched extract and normal extract were
tested at 500 µg/mL against V. fischeri, V. anguillarum, and V. parahaemolyticus. The normal
extract demonstrated potent inhibition against V. fischeri, PCA 17.9 ± 9.3, whereas the igi enriched
extract exhibited moderate inhibition against V. fischeri, PCA 63.3 ±6.7. Neither extract inhibited
V. anguillarum or V. parahaemolyticus. Percent control activity (PCA) determined in comparison
to the negative control (DMSO). The positive control, chloramphenicol, was tested at 2.5 µg/mL.
Data represented are average PCA values from three biological replicates.
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Leisingera sp. JC1 was also tested using a solid media assay against the three marine
vibrios above as well as P. leiognathi KNH6 and V. harveyi B392 to determine the zones of
inhibition (ZOI) (Figure 11). P. leiognathi, bioluminescent bacterium, was isolated from Hawaiian
seawater, and V. harveyi is another common marine pathogen. In order to mimic the environmental
bacterial concentrations four different densities were selected, 104-107 CFU/mL (Goecke et al.,
2010; Urakawa and Rivera, 2006). The results suggest that JC1 demonstrated differential activity
against the five vibrio species with more potent inhibition against V. fischeri and V. anguillarum
at all four densities (Figure 11A). There was significantly greater inhibition of V. fischeri at 104106 CFU/mL in comparison to 107 CFU/mL. The results also suggest that JC1 was more effective
at inhibiting P. leiognathi at lower densities, 104 and 105 CFU/mL. In addition, JC1 did not exhibit
inhibition of V. parahaemolyticus or V. harveyi.
Results from the ZOI assays and the 96-well assays were in agreement for V.
parahaemolyticus. However, for V. anguillarum, the results differed between the ZOI and 96-well
assay. Both extracts showed no inhibition against V. anguillarum whereas Leisingera sp. JC1 was
able to inhibit this vibrio strain in the ZOI assay. The difference in activity may be due to the
exclusion of aqueous soluble compounds during the extraction process. Moreover, compounds
may diffuse or interact differently in liquid versus solid media. Another proposed hypothesis is
that indigoidine may be reduced to leucoindigoidine under biological conditions and the reduced
state may be responsible for the antibacterial activity (Cude et al., 2012). Because leucoindigoidine
is easily converted to indigoidine in nonreducing conditions, testing the reduced state is difficult
in biological assays (Cude et al., 2012).
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Figure 11. Leisingera sp. JC1 demonstrates strong inhibition against V. fischeri and V.
anguillarum in zone of inhibition assays. (A) Leisingera sp. JC1 was tested against V. fischeri,
P. leiognathi, V. anguillarum, V. parahaemolyticus, and V. harveyi. The zone of inhibition was
determined around JC1 bacterial colonies using four different bacterial concentrations, 104
CFU/mL, 105 CFU/mL, 106 CFU/mL, and 107 CFU/mL on solid media. JC1 inhibited V. fischeri
and V. anguillarum at all four bacterial concentrations with significantly greater inhibition of V.
fischeri at 104-106 CFU/mL. JC1 inhibited P. leiognathi at 104 and 105 CFU/mL. However, no
inhibition was observed for P. leiognathi at the two higher bacterial concentrations, 106 and 107
CFU/mL. In addition, JC1 did not inhibit V. parahaemolyticus or V. harveyi. Letters above the bar
graphs indicate statistically significant differences between bacterial concentrations after data
analysis using post hoc Tukey tests. The following are 24 h images for JC1 tested against (B) no
vibrio species (C) V. fischeri (D) P. leiognathi (E) V. anguillarum (F) V. parahaemolyticus (G) V.
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harveyi. The bacterial concentration was 106 CFU/mL for (C-G) and scale bars are 5 mm (B-G).
[Dr. Andrea Suria generated data and figure.]
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Localization of Indigoidine Production by Leisingera sp. JC1
While performing ZOI assays the vibrio strains induced a distinct phenotypic change to
Leisingera sp. JC1. Leisingera sp. JC1 grown alone appeared to have uniform indigoidine
production (Figure 11B). However, in the presence of vibrio strains, JC1 appeared to localize
indigoidine production to the outer edges of the colony (Figure 11C-G). To investigate the
production of indigoidine across the JC1 bacterial colony, direct analysis in real time-mass
spectrometry (DART-MS) was selected. This mass spectrometry technique has been used to detect
natural products from microorganisms with minimal sample preparation required (Bouslimani et
al., 2014; Sanchez et al., 2011).
The production of indigodine across Leisingera sp. JC1 colonies was monitored over 7
days in the presence or absence of V. fischeri (Figure 12) and five locations were selected: center
(A), midpoint (B), edge (C), ZOI (D), and outside ZOI (E). Locations A-C were selected because
they were the areas of most interest due to pigmentation, and locations D-E were chosen to
determine if indigoidine permeated into the agar. The results indicate a relatively uniform
production of indigoidine across the JC1 colony in the absence of V. fischeri (Figure 12, locations
A-C). However, in the presence of V. fischeri indigoidine was found to localize to the edge of the
colony (Figure 12, location C) with minimal amounts of indigoidine present in the center and
midpoint (Figure 12, locations A-B). In both the absence and presence of V. fischeri, only trace
amounts of indigoidine were detected in the ZOI and outside the ZOI (Figure 12, locations D-E),
indicating that indigoidine is not diffusing into the agar.
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Figure 12. Utilization of DART-MS to monitor the localization of indigoidine production by
Leisingera sp. JC1 in the presence of V. fischeri. Direct analysis in real time-mass spectrometry
(DART-MS) was used to detect indigoidine production over 7 days by Leisingera sp. JC1 in the
absence (top images) and presence (bottom images) of V. fischeri. Five locations (A-E) were
selected across the colony. In the absence of V. fischeri, uniform production of indigoidine was
identified across the colony (locations A-C) whereas in the presence of V. fischeri indigoidine
localized towards the outer edges of the colony (location C). Minimal quantities of indigoidine
were detected in the zone of inhibition (ZOI) and outside the ZOI in the presence and absence of
V. fischeri (locations D-E). Heat map represents relative abundance of indigoidine production from
less abundance (black) to more abundance (bright red).
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The localization of indigoidine to the outer edges of JC1 colonies may be indicative of a
chemical defense mechanism to protect from V. fischeri, by localizing production to areas of direct
interaction with other microorganisms. Production of secondary metabolites for defense diverts
energy from the host’s biological functions such as growth and reproduction and thus may only be
advantageous at areas vulnerable to attack (Pawlik, 2012). Some sessile marine organisms such as
sponges and sea cucumbers allocate biologically active compounds to locations that are more
susceptible to harmful pathogens and predators (Furrow et al., 2003; Van Dyck et al., 2010).
Previous studies have shown induced pigment production through competitive bacterial
interactions (Hoshino et al., 2015; Carlson et al., 2015). For example, Staphylococcus aureus was
co-cultured with Pseudomonas aeruginosa displaying intense golden pigmentation at the outer
edges of the S. aureus colony (Antonic et al. 2013). This pigmentation was associated with
increased production of staphyloxanthin, an antioxidant compound (Antonic et al. 2013). In
another study, Tsukamurella pulmonis induced the production of actinorhodin and
undecylprodigiosin, antibiotic red pigments, from Streptomyces lividans (Onaka et al., 2011).
Similar to the aforementioned studies, Leisingera sp. JC1 exhibited increased localized
production of indigoidine at the outer edges of the colony in the presence of V. fischeri, likely as
a defense mechanism. Additional contributing factors that could be inducing indigoidine
production including homoserine lactones (Cude et al., 2015). In the Leisingera sp. Y4I strain, N(3-oxododecanoyl)-L-homoserine lactone (3-Oxo-C12:1-HSL) and N-octanoyl-homoserine lactone
(C8-HSL) were the dominant compounds produced at the exponential and stationary growth phase,
respectively (Cude et al., 2015). These homoserine lactones are hypothesized to induce the
production of indigoidine through initial synthesis of 3-Oxo-C12:1-HSL by the PhaI gene until
stationary phase. Then, increased concentrations of 3-Oxo-C12:1-HSL induces the pgaI gene to

33

produce C8-HSL resulting in indigoidine production (Cude et al., 2015). Another possible factor
could involve oxidation of leucoindigoidine to indigoidine at the edges of the JC1 colony by V.
fischeri (Heumann et al. 1964).

Regulation of Indigoidine Production by Leisingera sp. JC1
After determining the localization of indigoidine to the outer edges of the JC1 colony in
the presence of V. fischeri, liquid media co-culture experiments were performed with V. fischeri,
V. anguillarum, and V. parahaemolyticus to investigate the regulation of indigoidine production
in liquid culture with these additional vibrio strains (Figure 13). A monoculture of Leisingera sp.
JC1 and JC1 co-cultured with each of the vibrio strains was extracted using the centrifugation
method and indigoidine production was quantitated via HPLC. Controls included monocultures of
each vibrio strain that were extracted to confirm the vibrio strains were not producing indigoidine.
Leisingera sp. JC1 co-cultured with V. fischeri demonstrated a 1.38 fold upregulation of
indigoidine production. Conversely, JC1 co-cultured with V. anguillarum and V. parahaemolyticus
exhibited a 0.5 fold down regulation of indigoidine production. The differences in indigoidine
production were also visually observed in extract pigmentation with a dark blue extract for the coculture of JC1 with V. fischeri and pale blue extracts for co-cultures with V. anguillarum and V.
parahaemolyticus (Figure 13C). No pigmentation was seen in the extracts of each vibrio strain
(Figure 13A). The upregulation of indigoidine production by Leisingera sp. JC1 in the presence
of V. fischeri complemented the antibacterial activity exhibited from the in vitro biological assays
(Figures 10-11), strengthening the hypothesis that indigoidine may contribute to chemical defense
against V. fischeri. Additionally, the decreased production of indigoidine with V. anguillarum and
V. parahaemolyticus was consistent with the results from the 96-well liquid assay (Figure 10).
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Figure 13. Leisingera sp. JC1 upregulates indigoidine production in the presence of V.
fischeri. JC1 was cultured alone and in the presence of V. fischeri, V. anguillarum, and V.
parahaemolyticus (each vibrio was also monocultured). (A) Extracts were prepared in DMSO at
5 mg/mL for LC–MS (from left to right): JC1 monoculture, JC1 + V. fischeri, JC1 + V.
anguillarum, JC1 + V. parahaemolyticus, V. fischeri monoculture, V. anguillarum monoculture,
and V. parahaemolyticus monoculture. As shown, the highest pigment production was observed
when JC1 was co-cultured with V. fischeri. (B) LC–MS UV chromatograms (299 nm) for all
extracts. JC1 indigoidine production was upregulated when co-cultured with V. fischeri (red).
Down regulation was observed when co-cultured with V. anguillarum or V. parahaemolyticus
(green and pink, respectively). (C) Following extraction, indigoidine production was measured
using HPLC and quantitated via measurement of the area under the curve for UV absorption at
299 nm. Fold change was calculated as compared with JC1 monoculture.
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Conclusions
The Hawaiian bobtail squid and squid egg clutches are consistently interacting with an
abundance of environmental microorganisms including vibrio species (Mc-Fall Ngai, 2014;
Urakawa and Rivera, 2006). Although indigoidine was not solely responsible for the antimicrobial
properties of Leisingera sp. JC1, the differential biological activity observed against the vibrio
strains through in vitro biological assays (Figure 10 and 11) and increased production of
indigoidine in co-culture (Figure 13) likely contribute to the defense of squid eggs. In addition, the
light organ is in close proximity to the ANG, yet the light organ symbiont, V. fischeri, has not been
detected in the ANG (Collins et al., 2012). Thus, Leisingera sp. JC1 and other bacteria associated
with the ANG may produce secondary metabolites to prevent V. fischeri, from colonizing in the
ANG.
This study confirmed Leisingera sp. JC1, bacterial symbiont associated with E. scolopes,
produces indigoidine. Whole genome sequencing of JC1 identified the indigoidine biosynthetic
gene cluster, supporting the confirmation of indigoidine production. Leisingera sp. JC1 and
extracts from this isolate were shown to differentially inhibit marine vibrios through in vitro
assays. Interestingly, the normal extract (resin-based) demonstrated more potent inhibition against
V. fischeri than the indigoidine enriched extract suggesting indigoidine may not be solely
responsible for the biological activity. Moreover, ZOI assays and co-culturing of JC1 with V.
fischeri demonstrated localization and upregulation of indigoidine production, suggesting
indigoidine may contribute to the protective role for squid eggs. Future research will include
further characterization of secondary metabolites from Leisingera sp. JC1, investigating the
normal extract (resin-based) and indigoidine enriched extract for leucoindigoidine, and exploring
additional ANG bacteria to shed light on their potential role in the squid-vibrio symbiosis.
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Experimental
Bacterial Isolation
Euprymna scolopes, Hawaiian bobtail squid, was collected from sand flats in Maunalua
Bay, Oahu, Hawaii (21o16′ 51.42′′ N, 157o 43′ 33.07′′ W) and maintained in aquaria as previously
described (Schleicher and Nyholm, 2011). Eggs laid in captivity from one adult female were
collected, flash frozen on the 11th day of development, and stored at -80 oC. Ten eggs were thawed
for bacterial isolation and their outer capsules and embryos were removed and discarded with
sterile forceps. The JCs were isolated, surface sterilized with 70% ethanol, and rinsed with filtersterilized squid Ringers (FSSR, 530 mM NaCl, 25 mM MgCl2, 10 mM CaCl2, 20 mM HEPES, pH
= 7.5). The 10 JCs were pooled and homogenized in FSSR, then serially diluted and plated on
seawater tryptone medium (SWT; 5 g/L tryptone, 3 g/L yeast extract, 3 mL/L glycerol, 700 mL/L
Instant Ocean sea salts, 15 g/L agar, 300 mL/L DI water). Leisingera sp. JC1 colonies appeared
dark blue on this medium and were streaked to isolation.

Leisingera sp. JC1 large scale culture
Leisingera sp. JC1 was cultured in seawater tryptone media (SWTng; 5 g/L tryptone, 3 g/L
yeast extract, 700 mL/L Instant Ocean sea salts, 300 mL/L deionized water) using a three step
process optimized for the production of secondary metabolites (Ruiz et al., 2010). Briefly, small
scale cultures were prepared in a 24 deep well plate by inoculating a JC1 colony into 5 mL of
media. Then, medium scale cultures were prepared by transferring 1.5 mL of the small scale
cultures into 125 mL baffled flasks with 50 mL media. Lastly, large scale cultures were prepared
by transferring 15 mL of medium scale cultures into 1 L baffled flasks with 500 mL of media.
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Each culture was incubated for 3 days at room temperature while shaking at 125 rpm with the
exception of the small scale cultures that shook at 200 rpm.

Extraction of Leisingera sp. JC1
All solvents used for extraction were ACS grade and purchased from Sigma Aldrich (St.
Louis, MO, USA).
Normal Extraction: Leisingera sp. JC1 large scale culture was sonicated to lyse cells and
Diaion HP20 resin (Supelco, Bellefonte, PA, USA) was pre-washed with methanol followed by
Millipore water (EMD Millipore, Billerica, MA, USA). The pre-washed resin (10% w/v) was
added to the bacterial culture and allowed to incubate overnight at room temperature while shaking
at 125 rpm. The culture and resin were transferred to a coarse glass filter and washed with Millipore
water (2 x 150 mL) to remove media components and aqueous material. Subsequently, the resin
was sequentially extracted with methanol, dichloromethane, and acetone (2 x 150 mL). The
organic portions were combined, concentrated in vacuo, and extracted using ethyl acetate to
remove any remaining aqueous material.
Indigoidine-enriched Extraction: Because indigoidine is poorly soluble in water and most
organic solvents a different extraction method was used from literature with the following
modifications (Yu et al., 2013). Leisingera sp. JC1 large scale cultures were sonicated to lyse
cells, transferred to centrifuge tubes, and the cells were separated from the supernatant using low
centrifugation (850 g x 5 min; Beckman Coulter Avanti J-E Centrifuge, Brea, CA, USA). Then,
the supernatant was transferred to new centrifuge tubes and subjected to high centrifugation
(20,000 g x 10 min) to obtain an indigoidine pellet. The pellet was washed with methanol,
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transferred to a microcentrifuge tube, dried under N2 gas, and dissolved in dimethyl sulfoxide
(DMSO).

Detection of Indigoidine Production by Leisingera sp. JC1 via LC-MS
All solvents used were HPLC grade purchased from Sigma Aldrich. LC-MS data was
collected on an Agilent ESI single quadrupole mass spectrometer coupled to an Agilent HPLC
system with a G1311 quaternary pump, G1322 degasser, and a G1315 diode array detector.
Indigoidine enriched samples were prepared at 5 mg/mL in DMSO and analyzed using a linear
solvent gradient of 10% methanol in water to 90% methanol over 25 min on an Eclipse XDB-C18
(4.6 × 150 mm, 5 μm) RP-HPLC column. Indigoidine eluted at 10.7 min in agreement with
literature (Yu et al., 2013).

96-well Liquid Assays
Leisingera sp. JC1 extracts were tested for antimicrobial activity against V. fischeri ES114,
V. anguillarum 775, and V. parahaemolyticus KNH1. Development of these assays were based
upon growth curves, obtaining CFU counts, incubation temperature, endpoints, and determining
proper positive controls. These bioassays were performed according to Clinical and Laboratory
Standards Institute (CLSI) [formerly National Committee for Clinical Laboratory Standards
(NCCLS)] M07-A9) in 96-well plates (Corning Costar, Kennebunk, ME, USA) with the
following modifications. Each bacterial isolate was grown on SWT agar at 28 oC. Bacterial inocula
was prepared by adding select colonies into 5 mL of SWT media and adjusted to an OD600 0.080.13, equivalent to 0.5 McFarland Standard (approximately 1 x 108 CFU/mL).
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The bioassay was optimized for natural product extracts and the Leisingera sp. JC1 extracts
were screened as previously described (Zgoda and Porter, 2001) with the following modifications.
Briefly, master mix was prepared by the addition of 1.6 mL adjusted bacterial inoculum, 7.84 mL
sterile water, and 6.4 mL of SWT media. Each well consisted of 198 μL of master mix and either
2 μL of positive control (chloramphenicol, final testing concentration 2.5 μg/mL), negative control
(DMSO), or extract prepared in DMSO (screened at a final concentration of 500 μg/mL; MIC
performed using serial dilutions). Sterility control wells consisted of: 98 μL sterile water, 100 μL
of media, and 2 μL of DMSO. All of the controls and samples were tested in technical triplicates
and repeated in at least three biological replicates to confirm results. Plates were incubated at 28
oC

while shaking at 200 rpm and read at 600 nm every 2 h from 0-10 h with a final reading at 24

h using a Syngery H1 Hybrid Reader (Biotek, Winooski, VT, USA). Percent control activity (PCA)
calculated in comparison to the negative control (DMSO).

Zone of Inhibition Assays
Leisingera sp. JC1 was tested for a zone of inhibition against V. fischeri ES114, V.
anguillarum 775, V. parahaemolyticus KNH1, V. harveyi B392, and Photobacterium leiognathi
KNH6. Each vibrio strain was cultured at 30 oC in YTSS broth (4 g/L tryptone yeast extract, 2.5
g/L yeast extract, 15 g/L Instant Ocean sea salts) until stationary phase (2.5 h) followed by serial
dilutions from 107-104 CFU/mL using YTSS broth to evaluate density dependent inhibition. Each
dilution was spread evenly onto YTSS agar to form a lawn and tested in triplicate. Leisingera sp.
JC1 was cultured overnight in YTSS to a density of approximately 1 x 108 CFU/mL. Then, 10 μL
of the overnight culture was aliquoted onto each lawn in quadruplicate. The controls included 10
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μL of media control aliquoted onto each lawn and 10 μL of Leisingera sp. JC1 aliquoted in
quadruplicate onto YTSS agar without vibrio strains present as a growth control.

Localization of Indigoidine Production by Leisingera sp. JC1 Using DART-MS
Direct analysis in real time mass spectrometry (DART-MS) data was performed on an
AccuTOF (JEOL) with DART ion source (IonSense, Inc., Saugus, MA, USA). High purity helium
5.0-6.0 grade (greater than 99.999% purity) was heated to 300 oC and used for ionization. Five
locations were selected on JC1 colonies in the presence or absence of V. fischeri, including (A)
center of colony, (B) midpoint between center and edge of colony, (C) edge of colony, (D) ZOI
(in the absence of V. fischeri sample was obtained from a point equidistant from colony edge), and
(E) outside ZOI. At each location a sterile syringe needle (BD Medical, Franklin Lakes, NJ, USA)
was placed in the sample and then placed between the DART ion source and MS inlet. Positive
ion MS were obtained over a m/z range of 60-700 and relative percent abundance was obtained for
the indigoidine ion. Standards were run after sampling each colony and mass spectral data were
monitored in real time to ensure no residual indigoidine remained after each sample. DART-MS
is only semi-quantitative due to the potential for differential ionization, suppression of ions, and/or
changes in sample concentration in the DART ion source (Sanchez et al., 2011).

Measurement of Indigoidine Production by Leisingera sp. JC1 in Co-culture
Bacterial inoculum was prepared by adding select JC1 bacterial colonies into 5 mL of
SWTng media in a 24 deep well plate and allowed to incubate for 24 h at room temperature while
shaking at 200 rpm. Bacterial inocula for vibrios were prepared by adding select bacterial colonies
of each species separately into 5 mL of SWTng media in 24 deep well plates, incubated for 2 h at
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28 oC while shaking at 200 rpm. All bacterial inocula (JC1, V. fischeri, V. anguillarum, and V.
parahaemolyticus) were adjusted to OD600 0.1 before addition to co-cultures.
Co-cultures of JC1 with individual vibrios were prepared by adding 1 mL of adjusted JC1
inoculum to 10 mL SWTng media in 125 mL baffled flasks, incubated for 24 h at room temperature
while shaking at 125 rpm, followed by addition of 200 μL of V. fischeri, V. anguillarum, or V.
parahaemolyticus. After addition of the vibrio strain, co-cultures were incubated for an additional
24 h at room temperature while shaking at 125 rpm. Monocultures of JC1, V. fischeri, V.
anguillarum, and V. parahaemolyticus were prepared by adding 1 mL of adjusted inoculum to 10
mL SWTng media in 125 mL baffled flasks, incubated for 48 h while shaking at 125 rpm.
All co-cultures and monocultures were extracted using the indigoidine enriched protocol
described above. LC-MS data was obtained on the Agilent LC-MS system described above, using
an isocratic method to minimize baseline variation (10% acetonitrile in H2O with 0.1% formic acid
over 15 min at a flow rate of 1 mL/min with 20 μL injection volume). Extracts were prepared at 5
mg/mL in DMSO. Indigoidine was detected and quantitated via measurement of area under the
curve at UV absorbance 299 nm and confirmed by MS.
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Chapter III: Bacteria Associated with the Hawaiian Bobtail Squid Protect Eggs from Fungal
Fouling

Significant Contributions
Significant contributions to this chapter were made by the following researchers: Drs.
Allison Kerwin and Spencer Nyholm, University of Connecticut, performed the egg clutch
experiments; Dr. Sal Frasca, University of Florida, and Dr. Deanna Sutton, University of Texas
Health Science Center, isolated and identified F. keratoplasticum FSSC-2i and FSSC-2g from the
HI and CT egg clutch biofilm, and provided an additional strain, FSSC-2d, for antifungal testing;
Dr. Kerry O’Donnell, U.S. Department of Agriculture, completed multilocus sequence typing of
the F. keratoplasticum strains; Dr. Andrea Suria, University of Connecticut, isolated the ANG and
JC bacterial isolates used in this study; Robert Samples, University of Connecticut, obtained data
for Table 1; Dr. Jeremy Balsbaugh and the University of Connecticut Proteomics and
Metabolomics Facility acquired LC-MS/MS data. Portions of this chapter were published as:
Kerwin, A.H; Gromek, S.M.; Suria, A.M.; Samples, R.M.; Deoss, D.J.; O’Donnell, K.O.; Frasca,
S.; Sutton, D.A.; Wiederhold, N.P.; Balunas, M.J.; Nyholm, S.V. Shielding the next generation:
symbiotic bacteria from a reproductive organ protect bobtail squid eggs from fungal fouling, mBio,
2019, e02376-19.
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Introduction
The eggs and larvae of marine organisms are exposed to numerous microorganisms in the
ocean (Goecke et al., 2010). In this competitive environment, cephalopod egg clutches should be
vulnerable to fouling and biofilm formation due to lack of parental care (Lee et al., 2009). Despite
this, the eggs protect themselves from biofouling or predation during their embryonic development
period which can range from several weeks to months (Benkendorff et al., 2001; Montgomery and
McFall-Ngai, 1993). Therefore, eggs may rely on mechanisms such as chemical defense to ensure
successful development (Benkendorff et al., 2001).
In some cephalopods, one potential mechanism for egg defense may be associated with the
accessory nidamental gland (ANG), a reproductive organ present in female cephalopods, that
contains a diverse bacterial community (Kerwin and Nyholm, 2017; Collins et al., 2012). Although
the bacterial community of the ANG seems to vary among cephalopod species,
Alphaproteobacteria, Gammaproteobacteria, and Verrucomicrobia remain the dominant classes
of bacteria (Kerwin and Nyholm, 2017; Pichon et al., 2005; Collins et al., 2012). Bacteria from the
ANG are hypothesized to be added to the squid egg jelly coat (Figure 14B-C), yet the functional
role of the ANG and associated bacteria is poorly understood. Several proposed hypotheses for the
function of the ANG bacteria in eggs are participation in egg capsule formation (Buchner, 1965)
or protection of the developing embryos through bioactive secondary metabolite production
(Pichon et al., 2005; Barbieri et al., 1997; Biggs and Epel, 1991).
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Figure 14. Antibiotic treatment of squid egg clutches resulted in biofilm formation. (A)
Ventral dissection of Euprymna scolopes representing the close association of the nidamental
gland (NG), accessory nidamental gland (ANG), and light organ (LO). (B-C) Enlarged diagram
representing the ANG bacteria being deposited in the egg JC layers. (D-F) Squid egg clutches not
treated with antibiotics had the presence of bacteria in the JC layers. (G-H) Squid egg clutches
treated with antibiotics resulted in biofilm formation. (J) The biofilm was primarily composed of
a fungal isolate identified as Fusarium keratoplasticum. (K) In addition to the fungus, bacterial
cells were also found in the biofilm. (I) Electron micrograph images of antibiotic treated egg
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clutches confirmed the presence of fungal spores infiltrating the JC layers. (L) Egg clutches treated
with antibiotics for three days eliminated 98% of the bacteria within the egg JC. However, in both
untreated and antibiotic treated egg clutches the abundance of bacteria increased throughout
embryogenesis. [Dr. Allison Kerwin obtained data and generated figure.]

Investigating the function of bacterial symbionts such as the ANG bacteria in a hostmicrobe system is difficult (Lopanik, 2014). While the composition of the bacterial community
can be determined from 16S rRNA amplicon sequencing, studying interactions between its
microbial community using traditional culturing techniques is difficult because there may be
bacteria represented through sequencing that are unable to be cultured in laboratory conditions
(Wilson and Piel, 2013). Because there is increased bacterial diversity identified using 16S rRNA
amplicon community profiling, studying the relationship between the microbial symbionts and
their host are commonly based on identifying patterns and formulating hypotheses through
correlative studies as opposed to testing experimentally (Feldhaar, 2011). For example, correlative
studies have been performed with the accessory bacteria from pea aphids (Acyrthosiphon pisum)
to evaluate if there is a specific bacterium responsible for the potential resistance to the parasitoid
wasp (Aphidius eadyi) and fungal pathogen (Pandora neoaphidis) (Ferrari et al., 2004).
In order to reduce the complexity of host-microbe systems, researchers need tractable
experimental models such as the Hawaiian bobtail squid (McFall-Ngai, 2014). The binary
symbiosis of the bioluminescent bacterium V. fischeri in the squid light organ has been studied for
over 25 years (McFall-Ngai, 2014; McFall-Ngai and Ruby, 1991). Prior research has found these
squid are easily maintained in aquaria and the ANG bacterial composition remains stable
throughout embryonic development in captivity (Kerwin and Nyholm, 2017; Lee et al., 2009).
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Therefore, the Hawaiian bobtail squid can be utilized as a model system to investigate function of
the ANG bacteria.
In the current chapter, the functional role of bacteria associated with the ANG of E.
scolopes was investigated through chemical ecology, comparative metabolomics, and secondary
metabolite characterization. Several in vivo experiments were performed with squid egg clutches
including treating the eggs with antibiotics to eliminate bacteria in the eggs to investigate the
potential protective role of the ANG associated bacteria against environmental fungal pathogens.
In addition, individual eggs were dissected into various components to discern the antimicrobial
properties associated with the JC bacterial community. Since the JC has a diverse array of bacteria,
ANG and JC bacterial isolates were cultured, extracted, and evaluated using in vitro biological
assays to identify specific bacteria that may be responsible for the antimicrobial activity. Lastly,
comparative metabolomics was used to investigate secondary metabolites associated with ANG
and JC bacteria that may be induced in the presence of a fungal pathogen.

Results and Discussion
Antibiotic treatment of eggs leads to fungal fouling
To investigate the role of the JC bacterial community, egg clutches were treated with
antibiotics (either chloramphenicol or an antibiotic cocktail) (Figure 14G-I) eliminating 98% of
the bacteria within the egg JC after three days (Figure 14L). The egg clutches treated with
antibiotics developed a biofilm primarily composed of fungal hyphae (Figure 14J-K). In
comparison, untreated clutches subjected to the same conditions did not develop a biofilm
suggesting the production of defensive secondary metabolites by the JC bacteria (Figure 14D-F).
Antibiotic treated and untreated eggs were also subjected to conditions that did not promote fungal
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growth to determine the effect of antibiotic treatment on embryonic development (Appendix B1).
These conditions included cooler temperatures ranging from 15-20 °C (Kerwin, personal
observation) or sterile conditions. Both the antibiotic treated and untreated eggs maintained at
cooler temperatures and under sterile conditions exhibited similar hatch rates. Furthermore,
juveniles were able to successfully colonize Vibrio fischeri, the light organ symbiont, indicating
that antibiotic treatment did not significantly affect embryonic development or colonization of V.
fischeri in the light organ after hatching.
The fungal isolate from the biofilm was analyzed via multilocus sequence typing and
determined to be Fusarium keratoplasticum, haplotype FSSC-2g, originating from the Fusarium
solani species complex (FSSC). Similar to the experiment discussed above, a different set of squid
egg clutches were treated with antibiotics and maintained in flowing Hawaiian seawater. The eggs
also developed a biofilm primarily composed of F. keratoplasticum suggesting this fungus is also
found in the natural environment. The fungus from the Hawaiian biofilm was identified as F.
keratoplasticum haplotype FSSC-2i, closely related to F. keratoplasticum FSSC-2g (Connecticut
lab isolate). The Fusarium genus comprises filamentous fungi with at least 45 phylogenetically
distinct species within the FSSC, and members of this genus are known to infect plants (Coleman,
2016), immunocompromised humans (O’Donnell et al., 2008; O’Donnell et al. 2010), and marine
organisms (Fisher et al., 2012). A majority of the Fusarium species within this complex are known
to be resistant to antifungal drug treatments especially azoles (Al-Hatmi et al., 2017) and thus
amphotericin B is frequently used to combat fusarial infections.
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Symbiont-containing jelly coat is protective against fungal fouling
In another experiment squid eggs were dissected into their various components to
determine if the JC bacterial community or embryonic host factors may be responsible for
inhibition of fungal fouling (Figure 15). The eggs in this experiment were not subjected to
antibiotic treatment so the bacteria remained viable and capable of producing antimicrobial
compounds. The whole egg, JC and yolk sac, and yolk sac were challenged with F.
keratoplasticum FSSC-2g. Towards the end of embryonic development (by day 18 of
embryogenesis) there were fungal hyphae observed on the whole eggs, but the embryos remained
unaffected (Figure 15A-B). There were similar results for the eggs that had the outer capsule
removed, leaving the JC and its bacterial community intact (Figure 15C-D). However, removal of
the outer capsule and JC resulted in fungal growth, preventing embryonic development (Figure
15E-F). The results suggest the JC and associated bacteria may be responsible for the antifungal
activity.
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Figure 15. Euprymna scolopes embryos are susceptible to fungal fouling after removal of the
jelly coat. (A/C/E) Squid eggs remained untreated or (B/D/F) were challenged with F.
keratoplsaticum FSSC-2g. Three different components were tested for fungal fouling: (A-B) intact
eggs, (C-D) the outer capsule was removed exposing the jelly coat and embryo, (E-F) the outer
capsule and jelly coat were removed exposing the embryo. (F) The fungus was stained with Syto9
and observed using a confocal microscope. Yellow arrows highlight fungal hyphae. [Dr. Allison
Kerwin obtained data and prepared figure.]
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Symbiotic bacteria and their metabolites inhibit fungi
Tissue homogenates of the ANG and JC were serially diluted, plated onto agar, and bacteria
with unique morphology and pigmentation were isolated for further analysis. Select ANG and JC
bacterial isolates were cultured, extracted, and tested in a 96-well assay against three
phylogenetically related F. keratoplasticum strains, FSSC-2i (Hawaiian isolate), FSSC-2g
(Connecticut lab isolate), and FSSC-2d (human clinical strain) to investigate the possible
production of antifungal secondary metabolites by the ANG and JC bacteria (Figure 16). F.
keratoplasticum strains FSSC-2i and FSSC-2g were isolated from antibiotic treated egg clutches.
In contrast, F. keratoplasticum FSSC-2d was obtained from a lab in Texas and isolated from a
human cornea. After evaluating 33 ANG and JC bacterial extracts, over half of the extracts were
able to reduce at least 50% of the fusarial growth. More specifically, eight of these extracts
demonstrated strong inhibition (≤ 25% fungal growth), and nine additional extracts exhibited
moderate inhibition (26-50% fungal growth). Furthermore, five extracts displayed minimal
inhibition (51-75% fungal growth) against at least one F. keratoplasticum strain (Figure 16).
The ANG and JC bacterial extracts were also tested against Candida albicans (Figure 16),
a commensal yeast organism in healthy individuals but an opportunistic pathogen in
immunocompromised patients (Kim et al., 2011). The results suggest that ten out of 33 extracts
inhibited at least 50% fungal growth against C. albicans. There were five extracts that exhibited
strong inhibition and five additional extracts that demonstrated moderate inhibition. Additionally,
one extract displayed minimal inhibition. Several ANG and JC bacterial extracts either inhibited
C. albicans (e.g. Leisingera sp. M6, Leisingera sp. JC1, Leisingera sp. M7, Leisingera sp. ANG1)
or Fusarium spp. (e.g. Ruegeria sp. R, Ruegeria sp. ANG10, Pseudoalteromonas sp. JC22, and
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Alteromonas sp. JC21). These results suggest that ANG and JC bacterial extracts demonstrate
potent and selective activity against F. keratoplasticum and C. albicans.
Although there were six bacterial extracts that were able to inhibit at least 50% fungal
growth against all F. keratoplasticum strains, several extracts demonstrated selective activity by
inhibiting one or two strains (Figure 17C). There were also a greater number of extracts that either
had strong or moderate inhibition against the two environmentally-related F. keratoplasticum
strains, FSSC-2i and FSSC-2g, isolated from the egg clutch biofilm (Figure 17B). One possibility
is that the presence of F. keratoplasticum FSSC-2i and FSSC-2g in the surrounding environment
caused the ANG and JC bacteria to produce specific defensive metabolites against those two fungal
pathogens, although this remains to be tested.
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Figure 16. ANG/JC bacterial extracts demonstrate differential activity against fungal
pathogens. Bacterial extracts were tested against three Fusarium keratoplasticum strains and
Candida albicans, a human fungal pathogen. Overall, eight out of 33 bacterial extracts
demonstrated potent activity (≤25% fungal growth) and more than half of the bacterial extracts
exhibited moderate antifungal activity (≤50% fungal growth) against at least one F.
keratoplasticum strain. Additionally, five out of 33 extracts had strong inhibition against C.
albicans. Amphotericin B was used as the positive control at 4 µg/mL and 2.5 µg/mL against
Fusarium sp. and Candida sp., respectively. Data shown are average % growth values of technical
triplicates from at least two biological experiments.
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Figure 17. ANG/JC bacterial extracts demonstrate differential antifungal activity against the
three phylogenetically related F. keratoplasticum strains. (A) There were a greater number of
extracts with either strong or moderate inhibition against the environmentally-related F.
keratoplasticum strains, FSSC-2i and FSSC-2g, isolated from squid eggs whereas fewer extracts
were found to be active against the environmentally-unrelated F. keratoplasticum strain FSSC-2d.
(B) Six bacterial extracts were able to inhibit at least 50% fungal growth against all three F.
keratoplasticum strains. In contrast, several extracts demonstrated selective activity against only
one or two strains.
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Prior studies suggest that bacterial symbionts associated with invertebrates demonstrate the
ability to prevent fungal fouling. In Palaemon macrodactylus (caridean shrimp) an Altermonas
sp. bacterium was isolated from the surface of larvae and subsequently shown to produce 2,3
indolinedione (isatin) (Gil-Turnes et al., 1989). In vivo studies suggested that treatment of these
larvae with either Altermonas sp. culture or isatin inhibited colonization of Lagenidium callinectes,
a common marine fungal pathogen (Gil-Turnes et al., 1989). Another bacterium was isolated from
the embryos of Homarus americanus (American lobster) and found to produce 4hydroxyphenethyl alcohol (tyrosol) that also demonstrated inhibition of L. callinectes (Gil-Turnes
and Fenical, 1992). Symbiont mediated egg defense has also been observed in Lagria villosa
(beetles) coating their eggs in Burkholderia sp. This bacterium produces two compounds,
caryoynecin and sinapigladioside, that inhibit Purpureocillium lilacinum (Flórez et al., 2018;
Flórez et al., 2017). Fungal defense by symbiotic bacteria has also been displayed in the association
of Plethodon cinereus (red-backed salamander) with Janthinobacterium lividum, a bacterium that
produces the antifungal metabolites, violacein and indole-3-carboxaldehyde, inhibiting the growth
of Batrchochytrium dendrobatis (Harris et al., 2009). Thus, the production of secondary
metabolites by ANG and JC bacterial isolates to protect the eggs from fungal fouling is consistent
with the observation that use of defensive symbionts against pathogens is a common strategy in
marine and terrestrial organisms.

Induction of bacteria associated with squid eggs reveals secondary metabolites
Comparative metabolomics was used to explore antifungal secondary metabolites
associated with the JC bacteria that may be induced in the presence of F. keratoplasticum. For this
experiment, an egg clutch was divided into two portions. One portion was challenged with 104 bud
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cells/mL of F. keratoplasticum FSSC-2g (yellow arrow) and the other portion remained untreated
as a control (blue arrow) (Figure 18A). The egg clutch in this experiment was not subjected to
antibiotic treatment therefore leaving the JC bacteria remained viable and capable of producing
metabolites. LC-MS/MS molecular networking identified two clusters with metabolites only
present in the egg clutches challenged with F. keratoplasticum FSSC-2g (yellow circles) (Figure
18B). Further investigation of the first molecular cluster revealed three possible mycinamicin-like
derivatives (III, IV, and VI). The putative identification of mycinamicin-like derivatives was
compared to authenticated standards. Upon further examination of the raw LC-MS/MS data, there
were in-source fragments consistent with the desosamine moiety in mycinamicins. However,
additional analyses of the challenged egg clutch extract and authenticated standards via LCMS/MS displayed a difference in retention time that suggests the compounds within this cluster
may be more closely related to glycerophosphocholines. There are ongoing efforts to identify and
characterize the compounds within this cluster including investigating the effects on retention time
from the gelatinous JC.
The mycinamicins are 16-membered macrolides with

D-desosamine

and

D-mycinose

sugars originally isolated from an actinomycete Micromonospora griseorubida (Satoi et al., 1980;
Hayashi et al., 1983; Hayashi et al., 1981). This class of compounds has been well studied due to
the strong biological activity against gram positive bacteria (Satoi et al., 1980). Macrolides are
members of the polyketide class of natural products and are commonly composed of 14-,15-, or
16-membered macrocylic lactone rings with one or more sugars attached to the core lactone
structure (Zuckerman, et al. 2011). Prior studies demonstrated that a majority of macrolides inhibit
protein synthesis by binding to the 23S rRNA of the 50S bacterial ribosomal subunit (Zuckerman,
et al. 2011; Schluzen et al., 2001). The D-desosamine sugar associated with macrolides has been
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shown to have selectivity to bacterial ribosomes due to key hydrogen bonding interactions with
the 2'-OH and dimethylamino group in the binding site (Schluzen et al., 2001). Within the
mycinamicin-like molecular cluster there are three additional nodes with similar MS/MS
fragmentation patterns indicating the potential for structurally similar analogues. Three
mycinamicin standards, III, IV, and VI, were kindly provided by the laboratory of Dr. David
Sherman (University of Michigan) and tested in the 96-well assay against F. keratoplastium FSSC2g. Mycinamicins IV and VI demonstrated minimal inhibition with 73.4 % growth and 68.6 %
growth, respectively, and mycinamicin III had no antifungal activity.
In the second molecular cluster of interest, two glycerophosphocholines, lyso-PAF C:16
and lyso-PAF C:18 were initially identified from a database search, but ultimately found to slightly
differ from lyso-PAF C:16 and C:18. Purchased standards of lyso-PAF C:16 and C:18 as well as
a structural analogue PC 18:1/0:0 were tested in the 96-well assay against F. keratoplasticum
FSSC-2i and FSSC-2g. Lyso-PAF C:16 and lyso-PAF C:18 demonstrated weak antifungal activity
both with minimum inhibitory concentration (MIC) values of 125 µg/mL, while PC 18:1/0:0
exhibited more potent antifungal activity with MIC value of 31.3 µg/mL. PC 18:1/0:0 may
demonstrate stronger antifungal activity due to the unsaturation in the fatty acid tail causing more
effective penetration of the fungal cell membrane (Steinbuch et al., 2018). Additional
glycerophosphocholine derivatives were identified in challenged clutches, control clutches, and/or
fungal extract (Figure 18B). However, the lyso-PAF compounds present in challenged clutches
appear to be structurally distinct from the additional glycerophosphocholines identified in the
network (Table 1).
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Figure 18. Induction of secondary metabolites produced by bacteria associated with egg
clutches in the presence of Fusarium keratoplasticum. (A) An egg clutch was separated into two
portions. One portion was treated with F. keratoplasticum FSSC-2g and the other portion remained
untreated as a control. The egg clutch was not treated with antibiotics therefore allowing the
bacteria associated with the egg clutches capable of biosynthesizing antifungal secondary
metabolites. (B) LC-MS/MS molecular networking identified two clusters with metabolites only
present in egg clutches challenged with F. keratoplasticum FSSC-2g (yellow circles).
Furthermore, additional metabolites were found in control clutches (blue circles) and F.
keratoplasticum FSSC-2g (grey circles). Parent masses are represented within each node and the
thickness of the edge is based upon cosine similarity score.
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Table 1. Additional phosphocholines identified through the GNPS database from
challenged clutches, control clutches, and Fusarium keratoplasticum FSSC-2g extracts.

Putative
Identification
PC 0:0/14:0
PC 15:0/0:0
PC 16:1/0:0
PC 0:0/18:1d

Observed
m/z
[M+H]+ c
468.3049
482.3198
494.3265
522.3575

Mass
accuracy
(ppm)
7.6
8.9
4.8
4.0

Node
Theoretical
Sample
massb
m/z [M+H]+
Challenged clutches 468.231
468.3085
Challenged clutches 482.258
482.3241
Challenged clutches 494.256
494.3241
Challenged clutches 522.291
522.3554
F. keratoplastiucum
PC 18:2/0:0
FSSC-2g
520.276 520.3347
520.3398
9.7
F. keratoplastiucum
PC 18:3/0:0
FSSC-2g
518.259 518.3257
518.3252
0.9
Challenged and
PC 17:0/0:0d
control clutches
510.290 510.3581
510.3554
5.3
Challenged and
PC 17:0/0:0d
control clutches
510.290 510.3581
510.3554
5.3
Challenged and
PC 20:1/0:0
control clutches
550.321 550.3832
550.3867
6.4
Challenged and
PC 17:0/0:0d
control clutches
510.298 510.3581
510.3554
5.3
Challenged and
PC 0:0/18:0
control clutches
524.308 524.3744
524.3711
6.4
PC 0:0/16:0
All 3
496.268 496.3372
496.3398
5.2
PC 0:0/18:1d
All 3
522.291 522.3575
522.3554
4.0
a
features could represent one of several related isomers
b
consensus mass generated through GNPS
c
experimental spectra obtained using Waters Synapt G2-Si, processed with MassLynx V4.1
d
several nodes with similar masses were found in this cluster, likely representing isomers
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Platelet activating factors (PAFs) are potent biological mediators primarily produced by
cells involved in host defense (Sohlenkamp et al., 2003). These molecules are converted to lysoPAF by removing an acetyl group with acetylhydrolase, and lyso-PAF is reverted to PAF with
acetyltransferase (Quinn et al., 2016; Sohlenkamp et al., 2003). Lyso-PAFs are produced by
marine invertebrates including sponges (Quinn et al., 2016; Shin et al., 1999) and sea cucumbers
(Nishikawa et al., 2015). Several of these compounds have been shown to possess antibacterial
activity against gram positive bacteria (Steel et al., 2002) and antioxidant activity (Nishikawa et
al., 2015). Previous research suggests that bacterial compounds with a choline moiety (i.e., lysoPAFs) are usually in a close relationship, either symbiotic or pathogenic, with a eukaryotic host
that contributes choline for the biosynthesis of these compounds (Aktas et al. 2010; Sohlenkamp
et al., 2003). Thus far, lyso-PAF compounds have not been detected in the ANG and JC bacterial
extracts. However, these lyso-PAF derivatives may be produced by ANG and JC bacteria after
acquiring choline from the Hawaiian bobtail squid.
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Conclusions
Previous research revealed E. scolopes has an ANG primarily composed of a consortium
of diverse bacteria, although the function of the organ and the associated bacteria remained poorly
understood. The results discussed in this chapter reveal that the symbiotic bacteria associated with
the ANG has a defensive function. Overall, the ANG and JC bacteria demonstrated the ability to
protect developing embryos against fungal fouling. The presence of an ANG among other
cephalopods (Kerwin et al., 2018) suggests this defensive function may be conserved. The egg
clutches treated with antibiotics and dissected egg components challenged with F. keratoplasticum
FSSC-2g provide evidence that the JC bacterial community may be responsible for protection
against fungal fouling. The results from the 96-well antifungal assays suggested ANG and JC
bacterial extracts produce antifungal secondary metabolites that have the ability to inhibit both
filamentous and yeast fungal pathogens.
The potent antifungal activity of the ANG and JC bacterial extracts suggest this may be a
promising source for discovery and development of novel antifungal compounds. Fusarium
species are widely distributed in soil and are known to infect plants and humans (Coleman et al.,
2006; O’Donnell et al., 2008; O’Donnell et al. 2010). In addition to their impact on human disease,
FSSC fungi have emerged as marine pathogens, threatening extinction of endangered species
through their association with developing egg clutches (Fisher et al., 2012). Most importantly,
there is a need for new antifungal compounds since a majority of the species within the FSSC are
resistant to current antifungal treatments (O’Donnell et al., 2008).
Overall, there were a greater number of ANG and JC bacterial extracts that inhibited F.
keratoplasticum in comparison to C. albicans. The differential activity may be due to the presence
of F. keratoplasticum that was isolated from the antibiotic treated egg clutches and therefore
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present in the natural environment causing the ANG and JC bacteria to adapt and produce specific
defensive metabolites against F. keratoplasticum spp., although this remains to be investigated in
future studies. Utilization of comparative metabolomics identified mycinamicin-like and
glycerophosphocholine analogues that were induced in egg clutches challenged with F.
keratoplasticum FSSC-2g, and may contribute to symbiont mediated egg defense.
Although the specific JC bacteria responsible for the production of the mycinamicin-like
and glycerophosphocholine derivatives was not determined herein, future research should include
investigating other classes of bacteria represented in the ANG such as Verrucomicrobia and
Flavobacteria as well as continuing to analyze Proteobacteria that may possess the ability to
produce these compounds. Some of the ANG and JC bacteria may be difficult to culture under
laboratory conditions or only produce defensive secondary metabolites through interactions with
additional members of the JC bacterial community. Therefore, synergistic studies could include
testing one or more ANG and JC bacterial extracts in the 96-well assay or co-culturing the ANG
and JC bacterial isolates with F. keratoplasticum.

Experimental

Culture and Extraction
ANG and JC bacterial isolates were cultured in seawater tryptone media (SWT; 5 g/L
tryptone, 3 g/L yeast extract, 3 mL/L glycerol, 700 mL/L Instant Ocean sea salts, 300 mL/L
deionized water) using a three step process as previously described. Briefly, small scale cultures
were prepared in a 24 deep well plate by inoculating select colonies into 5 mL of media. Then,
medium scale cultures were prepared by transferring 1.5 mL of the small scale cultures into 125
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mL baffled flasks with 50 mL media. Lastly, large scale cultures were prepared by transferring 15
mL of medium scale cultures into 1 L baffled flasks with 500 mL of media. Each culture was
incubated for 3 days at 28 °C while shaking at 200 rpm.

Extraction of ANG and JC bacterial isolates
All solvents used for extraction were ACS grade and purchased from Sigma Aldrich (St. Louis,
MO, USA). ANG and JC large scale cultures were extracted as previously described. Briefly,
cultures were sonicated to lyse cells and Diaion HP20 resin (Supelco, Bellefonte, PA, USA) was
pre-washed with methanol followed by Millipore water (EMD Millipore, Billerica, MA, USA).
The pre-washed resin (10% w/v) was added to the bacterial culture and allowed to incubate
overnight at room temperature while shaking at 125 rpm. The culture and resin were transferred
to a coarse glass filter and washed with Millipore water (2 x 150 mL) to remove media components
and aqueous material. Subsequently, the resin was sequentially extracted with methanol,
dichloromethane, and acetone (2 x 150 mL). The organic portions were combined, concentrated
in vacuo, and extracted using ethyl acetate to remove any remaining aqueous material.

96-well antifungal bioassays
Fusarium spp.
ANG and JC bacterial extracts were tested for antifungal activity against three Fusarium
sp. strains, including F. keratoplasticum (FSSC-2i), F. keratoplasticum (FSSC-2g), and F.
keratoplasticum (FSSC-2d). Fusarium sp. fungal inocula was prepared as previously described
(Espinel-Ingroff et al. 1999) and the bioassays were performed according to the Clinical and
Laboratory Standards Institute (CLSI) [formerly National Committee for Clinical Laboratory
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Standards (NCCLS)] M38-A2 (2008) in 96-well flat bottom plates (Corning Costar, Kennebunk,
ME, USA) with the following modifications.
Each fungal isolate was grown on SWT agar supplemented with 50 µg/mL of
chloramphenicol at 28˚C. The mature fungus was covered with 3 mL of media, probed with a loop,
and the mixture was transferred into 10 mL of fresh media. The fungal mixture was vortexed,
allowed to settle, and the cell suspension below hyphae was transferred to a new falcon tube. The
cell suspension was adjusted to an OD600 0.15-0.17 and diluted 1:50 with media.
Each well consisted of 100 µL of the diluted fungal inoculum, 98 µL of media, and 2 µL
of either positive control (amphotericin B, final testing concentration 4 µg/mL), negative control
[dimethyl sulfoxide (DMSO)], or extract prepared in DMSO (final testing concentration 500
µg/mL). The extracts and controls were tested in technical triplicates with at least two biological
replicates to confirm the results. Plates were read on a Synergy H1 Hybrid Reader (Biotek,
Winooski, VT, USA) at 600 nm at 0 h, incubated at 28˚C, and then read again at 14 h. Percent
growth was calculated in comparison to DMSO (negative control).

Candida sp.
ANG and JC bacterial extracts were also tested against a human fungal pathogen Candida
albicans (ATCC 18804) following CLSI M27-A2 (2008) in 96-well flat bottom plates with the
following modifications. C. albicans colonies were selected from an agar plate and inoculated into
5 mL of RPMI media (Gibco®) was supplemented with 2% glucose, and then adjusted to an OD600
0.08-0.1 followed by a 1:10 dilution with fresh media. Each well consisted of 100 µL of the diluted
fungal inoculum, 98 µL of media, and 2 µL of either positive control (amphotericin B, final testing
concentration 2.5 µg/mL), negative control (DMSO), or extract prepared in DMSO (final testing
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concentration 500 µg/mL). The extracts and controls were tested in technical triplicates with at
least two biological replicates to confirm the results. Plates were read on a Synergy H1 Hybrid
Reader at 600 nm at 0 h, incubated at 35 °C, and then read again at 24 h. Percent growth was
calculated in comparison to DMSO (negative control).

Extraction of intact egg clutches challenged with F. keratoplasticum 2g
An egg clutch was divided into two portions. One portion was challenged with 104 bud
cells/mL F. keratoplasticum FSSC-2g for 11 days in filter-sterilized sea water at room temperature
with water changes and addition of fresh bud cells every two-three days. The second portion
remained untreated to be used as a control. The egg clutches were not treated with antibiotics.
Challenged and control egg clutches (5 mL volume each) were separately extracted with 2:1
DCM:MeOH (7 x 50 mL). Samples were sonicated, manually macerated with a metal spatula, and
incubated for 10 min at room temperature, after which solvent was filtered, combined, and
concentrated in vacuo resulting in 50.8 mg and 84.1 mg of challenged clutch extract and control
clutch extract, respectively.

LC-MS/MS Analyses and Molecular Networking
Extracts were analyzed via LC-MS/MS using a Synapt G2-Si coupled to an Acquity UPLC
system with an Acquity UPLC HSS T3 column (2.1 x 150 mm, 1.8 µM) connected to an Acquity
UPLC HSS T3 VanGuard pre-column (2.1 x 5 mm, 1.8 µM). at a flow rate of 0.45 mL/min.
Samples were prepared at 1 mg/mL in a 1:1 mixture of methanol/water and linear gradient elution
was performed at 0.45 mL/min with mobile phases A (water with 0.1% formic acid) and B
(acetonitrile with 0.1% formic acid) using the following conditions: 0.5 min hold at 95% A (0.1%
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formic acid in water) and 5% B (0.1% formic acid in acetonitrile), 3.5 min ramp to 60% B, 4 min
ramp to 98% B, 1 min hold at 98% B, 0.2 min ramp back to 5% B and a re-equilibration hold at
5% B for 1.8 min.
The instrument was operated in positive, resolution mode using the following parameters:
2 kV capillary voltage, 100 °C source temperature, 20V sampling cone, 800 L/h desolvation gas
flow, and 80V source offset. Data was obtained using an 11 min Fast data dependent acquisition
(Fast DDA) method with a 0.1 sec MS survey scan ranging from m/z 50-2000, followed by five
0.1 sec data-dependent MS/MS scans of ions with intensities greater than 1000 as determined
during the preceding scan event. Survey scans were acquired without collision energy (CE) and
MS/MS scans were acquired using a linear two-stage low mass (0-20V) and high mass (1040V) CE linear ramp. Lockspray real-time

mass

correction

was turned

on to

achieve

optimal mass accuracy by monitoring m/z 556.2771 and m/z 120.0813 ions from simultaneous
infusion of a 400 pg/µL leucine enkephalin solution (0.1% formic acid in a 50% water, 50%
methanol solution) with 0.1 sec scans, a 10 sec scan interval and 3 average scans per correction.
Data was converted to mzML format using ProteoWizard package (Chambers, et al. 2012)
and

processed

in

GNPS:

Global

Natural

Products

Social

Molecular

Networking

[http://gnps.ucsd.edu, (Wang et al., 2016)]. The following parameters were selected in GNPS for
the challenged and control clutch network: minimum cosine similarity score of 0.65 with at least
four matching peaks; parent mass tolerance of 1.0 Da; fragment ion tolerance 0.02 Da; and filter
peaks in a 50Da window was turned off. Files were imported into Cytoscape 2.8.3 and nodes
arranged with FM3 layout (Shannon, et al., 2003).
Standards and clutch extracts were confirmed using a Waters Xevo G2-XS QToF mass
spectrometer coupled to a Waters Acquity UPLC. Separations utilized a Waters Acquity UPLC
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HSS T3 column (2.1 x 50 mm, 1.8 µM, 100Å) connected to an Acquity UPLC HSS T3 VanGuard
pre-column (2.1 x 150 mm, 1.8 µM, 100Å). Conditions were identical to those described above
with the exception that MS/MS scans were acquired using a linear two-stage low mass (10-40V)
and high mass (40-80V) CE linear ramp. The instrument was operated in positive, sensitivity mode
using the following parameters: 3 kV capillary voltage, 100 °C source temperature, and 30V
sampling cone. Lockspray real-time mass correction used a simultaneous infusion of a 200 pg/µL
leucine enkephalin solution.
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Chapter IV: Chemical Networking Analyses to Identify Secondary Metabolites from
Labrenzia sp. ANG18, a Bacterial Symbiont

Significant contributions to this chapter were made by the following researchers. Drs.
Andrea Suria and Spencer Nyholm, University of Connecticut, isolated the ANG and JC bacteria
used for culture and extraction and analyzed the genome for Table 2.
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Introduction
Bacterial symbionts of host-microbe relationships are emerging as promising sources for
novel drug discovery due to the potential for the symbionts to produce biologically active
secondary metabolites that protect the host organism from predators and harmful pathogens (Lin
et al., 2016; Schmidt et al., 2012; Schmidt et al., 2008). As mentioned in the previous chapters the
Hawaiian bobtail squid, Euprymna scolopes, can be utilized as a model system to investigate
biologically active bacteria associated with the accessory nidamental gland (ANG), a female
reproductive organ. Prior research (Collins et al., 2012) has hypothesized that the ANG works in
conjunction with the nidamental gland (NG) to deposit bacteria in between the egg JC layers
(Figure 7). Subsequently, the JC bacteria are hypothesized to produce antimicrobial compounds
for chemical defense to protect the eggs from fungal fouling, biofilm formation, and/or predators
during their physically unprotected embryonic period.
The ANG bacterial community is dominated by bacteria from Alphaproteobacteria,
specifically from the Roseobacter clade, but also consists of Verrucomicrobia and
Gammaproteobacteria (e.g., Vibrio and Pseudoalteromonas) (Collins et al., 2015; Collins et al.,
2012). Within the class Alphaproteobacteria is the genus Labrenzia that consists of five species
typically originating from high salt environments (Schleisnner et al., 2017). These species are also
commonly found in marine environments affected by oil spills such as the Deepwater Horizon
spill (Schleissner et al., 2017; Fiebig et al., 2013). Crude oil is primarily composed of aliphatic and
aromatic hydrocarbons, and Labrenzia sp. have previously been reported to degrade these
hydrocarbons (Schleissner et al., 2017; Fiebig et al., 2013). Even though genomic analysis of
Labrenzia spp. has revealed their biosynthetic potential to produce secondary metabolites
including polyketides, thiopeptides, and terpenes (Rodrigues et al., 2018), this genus has not been
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thoroughly investigated for bioactive secondary metabolites. Recently, Labrenzia sp. PHM005
was isolated from marine sediment near Kenya resulting in the discovery of a novel pederin
analogue that demonstrated potent cytotoxic activity (Schleisnner et al., 2017). As a result of this
investigation, as well as the genomic analysis demonstrating substantial biosynthetic potential,
Labrenzia spp. may be a good source for novel drug discovery.
In the previous chapter, Labrenzia sp. ANG18, an accessory nidamental gland (ANG)
bacterial isolate, demonstrated potent antifungal activity against three phylogenetically related F.
keratoplasticum strains. For the current chapter, a suite of mass spectroscopic and nuclear
magnetic resonance techniques was used to isolate and identify biologically active constituents of
Labrenzia sp. ANG18. By integrating comparative metabolomics, biological assays, and microbial
interactions, defensive secondary metabolites can be prioritized for further analyses. The genome
of Labrenzia sp. ANG18 was analyzed using antibiotics and Secondary Metabolite Shell
(antiSMASH) (Weber et al., 2015) to identify known biosynthetic gene clusters. Lastly, the
isolation and partial characterization of a peptide produced by Labrenzia sp. ANG18 will be
discussed.

Results and Discussion

Chemical networking analyses identifies potential antimicrobial metabolites
In the previous chapter, bacterial isolates from the ANG and JC were cultured, extracted,
and tested for antifungal activity against three phylogenetically related F. keratoplasticum strains
within the Fusarium solani species complex (FSSC) and Candida albicans. The results suggested
eight of the ANG and JC bacterial extracts demonstrated strong inhibition (≤ 25% fungal growth)
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against at least one F. keratoplasticum strain. In addition, squid egg clutches were either
challenged with F. keratoplasticum to induce the production of defensive secondary metabolites
associated with the ANG and JC bacteria or remained untreated as the control.
To gain a better understanding of the functional role of the bacteria associated with the
ANG and identify key antifungal secondary metabolites, a molecular network was generated using
the challenged clutches, control clutches, ANG and JC bacterial extracts demonstrating potent
antifungal activity (≤ 25% fungal growth) against at least one F. keratoplasticum strain, and
bacterial extracts inactive against all three F. keratoplasticum strains (> 76% fungal growth)
(Figure 19). This molecular network identified features present in both the active bacterial extracts
and egg clutches (Figure 20). Seven features were identified in both the challenged clutches and
active extracts (≤ 25% fungal growth) demonstrating the biosynthetic potential of ANG and JC
bacteria to produce or upregulate antimicrobial metabolites when challenged with a pathogen.
Furthermore, three features were identified in both the control clutches and active extracts
suggesting there may be constitutively active metabolites.
As discussed in previous chapters, bacteria associated with the egg clutches are
hypothesized to prevent fungal fouling through the production of secondary metabolites.
Therefore, as shown in Figure 19, compounds produced in active bacterial extracts (blue circles),
compounds present in both the active ANG/JC bacteria and challenged clutches (pink squares),
and compounds present in both the active ANG/JC bacteria and control clutch extracts (turquoise
square) were prioritized for further analyses. One of the consensus nodes with m/z 393.1480 was
present in an active extract, Labrenzia sp. ANG18, and the control clutches (Figure 20). Because
we are interested in pursuing compounds that may be constitutively active due to the constant
exposure of the ANG/JC bacteria to microbial pathogens in the surrounding environment, we
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sought to identify the molecule and thus Antibase, a natural product database, was used to search
for the molecular weight. From the database, m/z 393.1480 was putatively identified as lincomycin
B, a derivative of the FDA-approved antibiotic, lincomycin A. The presence of lincomycin B in
Labrenzia sp. ANG18 was confirmed via LC-MS/MS using a commercial standard (Figure 21 and
22).

Figure 19. Utilization of comparative metabolomics to identify key biologically active
constituents produced by active ANG/JC bacterial extracts and egg clutches. Molecular
network generated to compare metabolites exclusively present in active ANG/JC bacterial extracts
(yellow circles; ≤ 25% fungal growth), inactive ANG/JC bacterial extracts (blue circles; > 76%
fungal growth), and metabolites present in both the active ANG/JC bacteria and challenged
clutches (pink squares) or metabolites present in both the active ANG/JC bacteria and control
clutch extracts (turquoise square).

72

Figure 20. Utilization of comparative metabolomics to identify biologically active
constituents produced by active ANG/JC bacterial extracts and egg clutches. Within the
network, seven features were found in both the active ANG/JC bacterial extracts and challenged
clutches, and three features were found in both the active ANG/JC bacterial extracts and control
clutches (teal squares). Furthermore, there were compounds present in inactive ANG/JC bacterial
extracts (> 76% growth) (blue circles) and compounds present in both inactive bacterial extracts
and control clutches and/or solvent (grey squares). Lincomycin B, [M+H]+ 393.1480, was
produced by an active bacterial extract (Labrenzia sp. ANG18) and the control clutches. The
compound was confirmed via comparison with a purchased standard using LC-MS/MS.
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Figure 21. Confirmation of the presence of lincomycin B in the control clutch extract
including extracted ion chromatogram (EIC) for lincomycin B ([M+H]+ m/z 393.2054, tR 2.79
min). Lincomycin A was not detected in the control clutches ([M+H]+ m/z 407.2210). Lincomycin
A and B standards (Santa Cruz Biotechnology, Inc., Dallas, TX) were authenticated using 1H NMR
and HRMS prior to LC-MS/MS comparison.
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Figure 22. Confirmation of the presence of lincomycin B in the Labrenzia sp. ANG18 extract
using LC-MS/MS extracted ion chromatogram for lincomycin B ([M+H]+ m/z 393.2054).
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The lincomycins were originally isolated from an actinomycete, Streptomyces lincolnensis
var. lincolnensis and have been extensively studied for the treatment of Gram-positive bacterial
infections (Barber and Waterworth, 1964), with lincomycin A receiving FDA approval in 1967.
Lincomycin biosynthesis involves the separate synthesis of 4-propyl-L-proline (PPL) and
methylthiolincosamide (MTL), condensation of PPL and MTL to form N-demethyl-lincomycin,
and methylation by S-adenosylmethionine to lincomycin A (Table 2) (Hou et al., 2018). The PPL
moiety is also found in additional antibiotics such as hormaomycin and sibiromycin, both produced
by Streptomyces spp. (Jiraskova et al., 2016).
In our 96-well antifungal assay, lincomycin A and B were tested at 250 µg/mL and did not
inhibit F. keratoplasticum FSSC-2i and FSSC-2g (> 76% fungal growth). However, further
analyses of Labrenzia sp. ANG18 via LC-MS/MS revealed putative classification of additional
secondary metabolites that will be discussed below. The identification of lincomycins in Labrenzia
sp. ANG18 and control egg clutches suggest that defense metabolites may be constitutively active
to protect the squid eggs from bacterial infection. Furthermore, to our knowledge this is the first
report of lincomycin derivatives produced by a bacterial isolate within Alphaproteobacteria.
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Table 2: Basic local alignment search tool (BLAST) analysis of Labrenzia sp. ANG 18 for
lmb genes.
Protein
Proposed function
Query cover
Amino acid identity
BLAST hit
(%)
(%)
lmbA
Propylproline
99
47
Scaffold 6.1
lmbB1
Propylproline
64
24
Scaffold 2.1
lmbB2
Propylproline
29
34
Scaffold 2.1
lmbC
Condensation
81
29
Scaffold
46.1
lmbD
Condensation
25
31
Scaffold 4.1
lmbE
Condensation
22
28
Scaffold
28.1
lmbF
Unknown
24
24
Scaffold
12.1
lmbG
Unknown
26
36
Scaffold
15.1
lmbIH
Regulation
50
30
Scaffold 3.1
lmbJ
Methylation
42
30
Scaffold
30.1
lmbK methylthiollincosaminide
54
34
Scaffold
33.1
lmbL
Unknown
52
33
Scaffold 3.1
lmbM
Unknown
94
32
Scaffold
15.1
lmbN methylthiollincosaminide
28
28
Scaffold 1.1
lmbZ
Unknown
74
28
Scaffold 1.1
lmbP methylthiollincosaminide
16
34
Scaffold 1.1
lmbO methylthiollincosaminide
54
34
Scaffold 8.1
lmbS
Unknown
90
32
Scaffold 1.1
lmbR methylthiollincosaminide
97
29
Scaffold 6.1
lmbQ
Regulation
19
39
Scaffold 3.1
lmbT
Condensation
14
29
Scaffold
12.1
lmbV
Condensation
16
35
Scaffold
13.1
lmbW
Propylproline
59
41
Scaffold 3.1
lmbX
Propylproline
94
30
Scaffold 5.1
lmbY
Propylproline
41
25
Scaffold 2.1
lmbU
Regulation
34
41
Scaffold 6.1
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In addition to the three features that were present in both the active bacterial extracts and
control clutches, there were seven features produced by both the active bacterial extracts and
challenged clutches (pink squares) (Figure 20). All of these molecular weights were analyzed
through the following databases: METLIN (Guijas et al., 2018) (https://metlin.scripps.edu/),
Global

Natural

Products

Social

Molecular

Networking

(GNPS;

https://gnps.ucsd.edu/ProteoSAFe/static/gnps-splash.jsp) (Wang et al., 2016), and Marinlit. Any
compound that was within 20 ppm mass accuracy of the molecular weight was fragmented in silico
using Mass Frontiers 7.0 (Hill et al., 2008) and the predicted fragmentation patterns were compared
to the experimental data. To date no known compounds have been identified from these features.
In the future, the molecular weights should be analyzed in additional natural product databases
such as Antibase and NP ATLAS (http://www.npatlas.org/joomla/). Also, additional ANG and JC
bacterial extracts analyzed via LC-MS or LC-MS/MS should be searched for the seven
compounds.

78

Genome characteristics of Labrenzia sp. ANG18
Labrenzia sp. ANG18 has a draft genome size of 6.8 Mb and a GC content of 59% which
is similar to other Roseobacter isolates (Table 3) (Gromek et al., 2016; Collins et al., 2015).
Analysis of the genome with antibiotics and Secondary Metabolite Shell (antiSMASH) (Weber et
al., 2015) revealed the capacity to produce secondary metabolites (Table 3) including homoserine
lactones, bacteriocin, and ectoine. In addition, a basic local alignment search tool (BLAST) search
identified lincomycin genes in the genome, supporting the presence of lincomycin B in the
bacterial extract (Table 2).
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Table 3. Genome statistics of Labrenzia sp. ANG18 and Antibiotics and Secondary
Metabolite Analysis Shell (antiSMASH) analysis of biosynthetic gene clusters in Labrenzia
sp. ANG18.
Genome Number
Size
of
(Mb)
Contigs
6.8

51

N50
(bp)

G+C
Fold
Content Coverage
(%)
(%)

371,108

59

9.5

Number
antiSMASH
of
gene cluster
predicted
prediction
clusters
Homoserine
lactone

4

Bacteriocin

2

Ectoine

1
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Isolation of a proposed peptide
One of the ANG bacterial extracts, Labrenzia sp. ANG18, demonstrated potent antifungal
activity against all three F. keratoplasticum strains and moderate activity against C. albicans
(Figure 23). However, the bacterial extract did not exhibit anti-proliferative activity against breast
cancer cells (MCF-7) (Figure 23). The bacterial extract was fractionated using reverse-phase high
performance liquid chromatography (C18 HPLC) and tested against F. keratoplasticum FSSC-2g.
Preliminary results suggest the fraction demonstrates moderate antifungal activity (data not shown,
confirmatory testing ongoing). Due to the antifungal activity and presence of peak that overlapped
with lincomycin A via LC-MS (Figure 24), this fraction was selected for further purification
resulting in the isolation of compound 1 (MB0341AE4), described below. Antifungal testing of
compound 1 is ongoing to determine if this compound contributes to the potent activity of the
crude extract.

81

Figure 23. Antifungal and anti-proliferative activity of Labrenzia sp. ANG18 extract
(MB0341) against F. keratoplasticum, C. albicans, and MCF-7 breast cancer cells. (A)
Labrenzia sp. ANG 18 demonstrated potent activity against all three strains of F. keratoplasticum
and (B) exhibited moderate activity against C. albicans. (C) However, the extract exhibited no
anti-proliferative activity against MCF-7 cells (positive controls: amphotericin B for F.
keratoplasticum and C. albicans, and doxorubicin for MCF-7).
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Figure 24. HP-LC chromatogram of Labrenzia sp. ANG18 fraction (MB0341AE) (red) and
lincomycin A standard (blue).
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Partial characterization of compound 1
The 1H NMR spectrum for compound 1 (Figure 25A) indicated the presence of a parasubstituted phenyl group, two methyls, seven methylenes, and four methines, which were
confirmed using the DEPT135 NMR (Figure 25B). The

13

C NMR spectrum (Figure 25C)

suggested the presence of three carboxyls at δC 170.4, 168.7, and 164.9. The COSY NMR
correlation between the two methyls at δH 1.12 and 0.96 to the methine at δH 2.51 (Figure 26), and
the HMBC correlation between the methyl protons and the methine carbon (δC 60.2) confirmed an
isopropyl substructure (Figure 28). A hydroxyl group was determined to be at position C-6 of the
para-substituted phenyl group due to the downfield shift δC 155.6 and HMBC correlations of the
aromatic protons at δH 6.72 and 7.06 to C-6 (Figure 28). There were strong HMBC correlations of
H-7 to C-2 and C-4 confirming an adjacent methylene and HMBC correlations of H-7 to one of
the carboxyls (C-9) (Figure 28).
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Figure 25. 1H NMR (A), DEPT135 NMR (B), and 13C NMR (C) spectra of MB0341AE4.
Spectra were collected at 500 MHz for 1H and 125 MHz for 13C in CD3OD.
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Conclusions
Utilizing comparative metabolomics, antifungal activity, and experimentally-driven
microbial interactions from egg clutch experiments prioritized secondary metabolites present in
the active bacterial extracts and either the challenged clutches or control clutches for further
investigation. The results suggest lincomycin B is present in both the control clutches and
Labrenzia sp. ANG18. Whole genome sequencing of Labrenzia sp. ANG18 confirmed the
presence of lincomycin biosynthesis genes, strengthening the evidence that Labrenzia sp. ANG18
is able to produce lincomycin B.
Overall, there are 10 mass spectral features of interest. Three features were found in both
the control clutches and active bacterial extracts and one of those was identified as lincomycin B.
In addition, there were seven features present in both the challenged clutches and active bacterial
extracts that have yet to be identified. Future studies will include comparing masses of the
unknown features to other natural product databases and searching for these features in additional
ANG and JC bacteria extracts.
Labrenzia sp. ANG18 was pursued for additional secondary metabolites due to the potent
activity against F. keratoplasticum and C. albicans. Using a suite of NMR analyses, the structure
of a proposed peptide has been partially elucidated. Future research will include final structure
elucidation of the isolated compound and testing in the 96-well antifungal assays. Additionally,
further investigation of additional bioactive bacterial extracts is ongoing.
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Experimental

ANG and JC bacterial cultures
ANG and JC bacterial isolates were cultured in seawater tryptone media (SWT; 5 g/L
tryptone, 3 g/L yeast extract, 700 mL/L Instant Ocean sea salts, 300 mL/L deionized water) using
a three-step process optimized for the production of secondary metabolites. Briefly, small-scale
cultures were prepared in a 24-deep-well plate by inoculating select bacterial colonies into 5 mL
of media. Then, medium-scale cultures were prepared by transferring 1.5 mL of the small-scale
cultures into 125 mL baffled flasks with 50 mL media. Lastly, large-scale cultures were prepared
by transferring 15 mL of medium-scale cultures into 1 L baffled flasks with 500 mL of media.
Each culture was incubated for 3 days at 28 °C while shaking at 200 rpm.

Extraction of ANG and JC bacterial cultures
All solvents used for extraction were ACS grade and purchased from Sigma Aldrich (St.
Louis, MO, USA).
ANG and JC large-scale cultures were sonicated to lyse cells. Diaion HP20 resin (Supelco,
Bellefonte, PA, USA) was pre-washed with methanol followed by Millipore water (EMD
Millipore, Billerica, MA, USA) and pre-washed resin (10% w/v) was added to the bacterial cultures
and allowed to incubate overnight at room temperature while shaking at 125 rpm. The culture and
resin were transferred to a coarse glass filter and washed with Millipore water (2 x 150 mL) to
remove media components and aqueous material. Subsequently, the resin was sequentially
extracted with methanol, dichloromethane, and acetone (2 x 150 mL). The organic portions were
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combined, concentrated in vacuo, and extracted using ethyl acetate to remove any remaining
aqueous material.

Antifungal assays
The 96-well antifungal assays were performed using the same method described in Chapter
3.

LC-MS/MS analyses and molecular networking
Extracts were analyzed via LC-MS/MS using a Synapt G2-Si coupled to an Acquity UPLC
system with an Acquity UPLC HSS T3 column (2.1 x 150 mm, 1.8 µM) connected to an Acquity
UPLC HSS T3 VanGuard pre-column (2.1 x 5 mm, 1.8 µM). at a flow rate of 0.45 mL/min.
Samples were prepared at 1 mg/mL in a 1:1 mixture of methanol/water and linear gradient elution
was performed at 0.45 mL/min with mobile phases A (water with 0.1% formic acid) and B
(acetonitrile with 0.1% formic acid) using the following conditions: 0.5 min hold at 95% A (0.1%
formic acid in water) and 5% B (0.1% formic acid in acetonitrile), 3.5 min ramp to 60% B, 4 min
ramp to 98% B, 1 min hold at 98% B, 0.2 min ramp back to 5% B and a re-equilibration hold at
5% B for 1.8 min.
The instrument was operated in positive, resolution mode using the following parameters:
2 kV capillary voltage, 100 °C source temperature, 20V sampling cone, 800 L/h desolvation gas
flow, and 80V source offset. Data was obtained using an 11 min Fast data dependent acquisition
(Fast DDA) method with a 0.1 sec MS survey scan ranging from m/z 50-2000, followed by five
0.1 sec data-dependent MS/MS scans of ions with intensities greater than 1000 as determined
during the preceding scan event. Survey scans were acquired without collision energy (CE) and
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MS/MS scans were acquired using a linear two-stage low mass (0-20V) and high mass (10-40V)
CE linear ramp. Lockspray real-time mass correction was turned on to achieve optimal mass
accuracy by monitoring m/z 556.2771 and m/z 120.0813 ions from simultaneous infusion of a 400
pg/µL leucine enkephalin solution (0.1% formic acid in a 50% water, 50% methanol solution) with
0.1 sec scans, a 10 sec scan interval and 3 average scans per correction.
Data was converted to mzML format using ProteoWizard package (Chambers, et al. 2012)
and

processed

in

GNPS:

Global

Natural

Products

Social

Molecular

Networking

[http://gnps.ucsd.edu, (Wang et al., 2016)]. The network with active extracts, inactive extracts,
clutches challenged with F. keratoplasticum 2g, and control clutches utilized the same parameters
with the exception of having a fragment ion tolerance of 0.3 Da. The following active extracts (≤
25% growth against at least one Fusarium spp.) were grouped together: Labrenzia sp. ANG18,
Leisingera sp. ANG-S2, Leisingera sp. ANG15, Ruegeria sp. ANG-R, Ruegeria sp. ANG10,
Alteromonas sp. JC21, Pseudoalteromonas sp. JC22, and Vibrio sp. JC34. In a separate group, the
following inactive extracts (>76% growth against all three Fusarium spp.) included: Ruegeria sp.
ANG17, Leisingera sp. ANG-M1, Leisingera sp. ANG-S, Leisingera sp. ANG-VP, Nautella sp.
ANG-M5, Leisingera sp. ANG-M7, Leisingera sp. ANG1, Ruegeria sp. ANG6, Leisingera sp.
ANG-DT, Leisingera sp. ANG-S3, Tateyamaria sp. ANG-S1, and Tenacibaculum sp. JC62. Files
were imported into Cytoscape 3.5.1 and nodes arranged with the default layout.
Standards and clutch extracts were analyzed using a Waters Xevo G2-XS QToF mass
spectrometer coupled to a Waters Acquity UPLC. Separations utilized a Waters Acquity UPLC
HSS T3 column (2.1 x 50 mm, 1.8 µM, 100Å) connected to an Acquity UPLC HSS T3 VanGuard
pre-column (2.1 x 150 mm, 1.8 µM, 100Å). Conditions were identical to those described above
with the exception that MS/MS scans were acquired using a linear two-stage low mass (10-40V)
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and high mass (40-80V) CE linear ramp. The instrument was operated in positive, sensitivity mode
using the following parameters: 3 kV capillary voltage, 100 °C source temperature, and 30V
sampling cone. Lockspray real-time mass correction used a simultaneous infusion of a 200 pg/µL
leucine enkephalin solution.

96-well anti-proliferative assays with solid tumor cells (Gromek et al., 2016)
Cell line maintenance
Breast cancer cells (MCF-7) were obtained from the American Type Culture Collection
(ATCC, Manassas, VA). MCF-7 cells were cultured in DMEM media (Gibco) supplemented with
10% FBS and 1 penicillin/streptomycin. The cells were grown in Corning Cell Culture, canted
neck T75 (Fisher Scientific) in an Autoflow IR water-jacketed CO2 incubator (37 °C, 5% CO2).
Experiments performed in Celltreat Tissue Culture Treated 96 well flat bottom plates. DMSO was
used to prepare all drug solutions and the final DMSO concentration was not greater than 1%.

Cell viability assay
Anti-proliferative activity of Labrenzia. sp. ANG18 extract against MCF-7 cells were
evaluated using a standard MTS-PMS assay. Briefly, a 96 well plate was seeded at 3,000 cells per
well. Before the addition of test compounds, plates were incubated at 37 °C with 5% CO2 for 24
h. Then, 1 µL of test compound was added to the well and then incubated for another 72 h. The
extract was screened at 100 µg/mL. Positive control for experiments were doxorubicin at 10 µM
and DMSO was used as the negative control. MTS and PMS reagents were prepared according to
the protocol below and the two reagents were mixed at a ratio of 20 (MTS):1 (PMS). Then, 20 µL
of the MTS/PMS solution was added to each well. The plate was incubated for another 3 h and
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then the absorbance of the wells were measured using a Synergy H1 Hybrid Reader (Biotek) at
490 nm. All experiments were repeated at least two independent times performed in triplicate.

Preparation of MTS and PMS reagents
MTS reagent (Promega Celltiter 96) was dissolved in sterile PBS (UConn Cell Culture
Facility) to make a 2 mg/mL solution. Phenazine methosulfate (PMS) reagent (Sigma) was
dissolved in sterile PBS to make a 0.92 mg/mL solution. MTS and PMS reagents were stored at 20 °C until needed.

Isolation and structure elucidation of compound 1
High performance liquid chromatography (HPLC) and was performed on an Agilent 1260
HPLC system with a G1311 quaternary pump, G1322 degasser, and a G1315 diode array detector
using an Eclipse XDB-C18 (4.6 × 150 mm, 5 μm) RP-HPLC column. Labrenzia sp. ANG18 was
pre-fractionated using an isocratic gradient at 55% acetonitrile (ACN) followed by purification
using an isocratic gradient at 8% ACN to afford 1.4 mg of pure compound. NMR spectra were
obtained with a Bruker AVANCE 500 MHz spectrometer using MeOD4 as reference and analysis
was performed on MestReNova version 12.0.

LC-MS profiles of Labrenzia sp. ANG18
High performance liquid chromatography (HPLC) and was performed on an Agilent 1260
HPLC system with a G1311 quaternary pump, G1322 degasser, and a G1315 diode array detector
coupled to an Agilent ESI single quadrupole mass spectrometer. Gradient elution was used from
25% acetonitrile in 0.1% formic acid (ACNFA)in H2O in 0.1% formic acid to 100% ACNFA, with
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a 0.7 mL/min flow rate and a 25 µL injection volume (extract prepared at 1 mg/mL in HPLC grade
methanol) using an Eclipse XDB-C18 (4.6 × 150 mm, 5 μm) RP-HPLC column. Chemical profiles
were monitored at three different UV absorbances (209 nm, 254 nm, and 299 nm) as well as
positive and negative mode total ion chromatograms as measured via mass spectrometry. Agilent
Chemstation software vB04.02 was used to quantitate area under the curve vial manual integration
of peaks at UV absorbance 254 nm to determine purity.
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Figure 26. 1H-1H COSY NMR spectra of MB0341AE4. Spectra was collected in CD3OD.
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Figure 27. 1H-13C HSQC NMR spectra of MB0341AE4. Spectra was collected in CD3OD.
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Figure 28. 1H-13C HMBC NMR spectra of MB0341AE4. Spectra was collected in CD3OD.
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Chapter V. Conclusions and Future Directions
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Host-microbe symbioses between a eukaryotic host and bacterial symbiont have
traditionally been studied to gain a better understanding of the ecological relevance or nutritional
exchange among organisms (Schmidt et al., 2012; Lopanik et al., 2014). However, microbial
symbionts associated with host organisms are emerging as a promising source for novel drug
discovery because of the potential for bacterial symbionts to produce biologically active
compounds (Schmidt et al., 2012; Schmidt et al., 2008). Defensive symbioses have been
investigated in terrestrial and marine invertebrate host-microbe relationships where the bacterial
symbiont produces secondary metabolites to either inhibit harmful pathogens or ward off predators
(Kaltenpoth et al., 2014; Schmidt et al. 2012; Schmidt et al., 2008; Cafaro et al., 2011; Koehler et
al., 2013; Kroiss et al., 2010; Hildebrand et al. 2004, Haygood and Davidson, 1997; Gil-Turnes et
al., 1989).
In marine invertebrates, the host-microbe relationships of sessile organisms (e.g., sponges,
corals, tunicates) with their associated microorganisms are often studied because sessile organisms
lack mobility and some of their bacterial symbionts are known to produce compounds useful for
defense against predators and harmful pathogens (Schmidt et al., 2012; Schmidt et al., 2008). In
mobile organisms (e.g., shrimp, squid) bacterial symbionts may also produce compounds for
chemical defense, but have typically been related to protection of eggs or larval stages (Gil-Turnes
and Fenical, 1992; Gil-Turnes et al., 1989; Fraune et al., 2015; Flórez et al., 2015; Lopanik et al.,
2014).
A beneficial host-microbe symbiotic relationship that has been well studied is the
interaction of the Hawaiian bobtail squid, Euprymna scolopes, with the bioluminescent bacterium
Vibrio fischeri within the squid light organ (Nyholm et al, 2002; Nyholm et al.; 2003; Visick et
al., 2000; McFall-Ngai, 2014). In addition to the light organ, female E. scolopes have an accessory
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nidamental gland (ANG) that harbors a diverse bacterial consortium primarily composed of
Alphaproteobacteria, Gammaproteobacteria, and Verrucomicrobia (Kerwin and Nyholm, 2017;
Collins et al., 2012). While previous research has determined that the nidamental gland (NG) of
E. scolopes is responsible for producing the JC that surrounds squid eggs, the function of the ANG
and associated bacteria has been poorly characterized (Kerwin and Nyholm, 2017; Collins et al.,
2015; Collins et al., 2012). Using the Hawaiian bobtail squid as a model organism, the research
highlighted in this dissertation has focused on identifying biologically active compounds
associated with the ANG and JC bacteria to gain a better understanding of the role of the ANG
and the symbiotic relationship of the bacterial community present in the JC.
In chapter 2, a bacterium isolated from the jelly coat of squid egg clutches, Leisingera sp.
JC1, was investigated for antimicrobial compounds due to similar pigmentation and colony
morphology as a Leisingera sp. Y4I bacterial strain that had been reported to produce an
antimicrobial compound known as indigoidine (Cude et al., 2012). This study utilized mass
spectrometry techniques [liquid chromatography mass spectrometry (LC-MS) and direct analysis
in real time mass spectrometry (DART-MS)], in vitro biological assays, and co-culture
experiments to explore the functional role and regulation of indigoidine when exposed to the light
organ bacterial symbiont of E. scolopes, V. fischeri, and additional common marine vibrios. The
production of indigoidine by Leisingera sp. JC1 was confirmed using LC-MS, and the presence of
this compound mayb be contributing to the microbial defense of squid eggs.
To further understand the potential antimicrobial activity of indigoidine the two Leisingera
sp. JC1 extracts, a normal resin-based extract and an indigoidine-enriched extract, tested in a 96well assay. Both chemical extracts were screened at 500 µg/mL against V. fischeri, V. anguillarum,
and V. parahaemolyticus. Intriguingly, the normal extract demonstrated more potent inhibition of
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V. fischeri than the indigoidine-enriched extract suggesting that indigoidine may not be solely
responsible for the biological activity. Further analysis by LC-MS showed that the normal extract
had only trace quantities of indigoidine present. Neither chemical extract inhibited V. anguillarum
or V. parahaemolyticus.
The zone of inhibition assays demonstrated that Leisingera sp. JC1 was able to inhibit V.
fischeri, V. anguillarum (common marine pathogen), and Photobacterium leiognathi
(bioluminescent bacterium isolated from Hawaiian seawater). However, there was no inhibition of
V. parahaemolyticus or V. harveyi. There may have been differential activity demonstrated
between the ZOI and 96-well assays for V. anguillarum because compounds diffuse differently in
solid media compared to liquid media, the extracts do not have aqueous soluble compounds, or
possible changes in the redox state of indigoidine. Furthermore, Leisingera sp. JC1 and other
associated bacteria within the ANG may produce secondary metabolites to prevent V. fischeri from
colonizing in the ANG.
The zone of inhibition assays resulted in a significant difference in pigmentation of
Leisingera sp. JC1 bacterial colonies in the presence and absence of V. fischeri. In the absence of
V. fischeri, there was uniform production of indigoidine across the colony whereas in the presence
of V. fischeri there was localization of indigoidine production to the outer edge of the colony.
Therefore, DART-MS was used to confirm the localization of indigoidine production to the outer
edge of the colony in the presence of V. fischeri. The localization of indigoidine to the outer edges
of the colony may be indicative of use as a chemical defense mechanism to protect against V.
fischeri and potentially other marine pathogens.
To investigate the regulation of indigoidine production, Leisingera sp. JC1 was co-cultured
with V. fischeri, V. anguillarum, and V. parahaemolyticus. When Leisingera sp. JC1 was co-
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cultured with V. fischeri there was upregulation of indigoidine production which complemented
the ZOI and 96-well antimicrobial assays. Conversely, there was down regulation of indigoidine
when Leisingera sp. JC1 was co-cultured with V. anguillarum and V. parahaemolyticus. Within
the Hawaiian bobtail squid, the light organ is anterior to the ANG yet V. fischeri has not been
detected in the ANG. Thus, one role of Leisingera sp. JC1 and other ANG/JC bacterial isolates
may prevent the colonization of V. fischeri in the ANG. More broadly, Leisingera sp. JC1 and
other ANG/JC bacterial isolates may play a role in egg defense by producing antimicrobial
compounds to protect the physically unprotected egg clutches during their embryonic period.
In chapter 3, bacteria associated with the ANG demonstrated the ability to protect
developing embryos from fungal fouling suggesting the symbiotic bacteria has a defensive
function. In vivo experiments subjecting egg clutches to antibiotics killing bacteria from the
surface of the eggs and in between the JC layers. Eggs treated with antibiotics developed a thick
biofilm primarily consisting of a fungal isolate identified as Fusarium keratoplasticum, whereas
eggs that were not treated with antibiotics did not have biofilm formation. Additional controls
included the treatment of egg clutches with only antibiotics to ensure the antibiotics were not
affecting the development and growth of the embryos.
In a separate experiment, squid eggs were dissected to determine if host factors or the JC
bacterial community was responsible for the antifungal activity. These eggs were not treated with
antibiotics so the bacteria remained viable and capable of producing antimicrobial compounds.
The whole eggs, JC and yolk sac (outer capsule removed), and yolk sac alone were challenged
with F. keratoplasticum. There were fungal hyphae observed on the intact eggs but embryonic
development was not affected. After the outer capsule was removed, leaving the JC and its
bacterial community intact, the results were similar to the whole eggs. However, removal of the

100

outer capsule and JC resulted in fungal formation and prevented embryonic development,
suggesting the JC and associated bacteria may be responsible for the antifungal activity. The results
from the antibiotic treated egg clutch and dissection experiment stimulated an interest to
investigate the ANG and JC bacteria for potent biologically active compounds.
Bacterial isolates from the ANG and JC were cultured, extracted, and tested in a 96-well
assay against three phylogenetically related F. keratoplasticum strains. The results suggest that
over 60% of the ANG and JC bacterial extracts are able to reduce fungal growth. More specifically,
eight of the 33 extracts demonstrate strong inhibition (0-25% growth) and an additional 9 extracts
exhibit moderate inhibition (26-50% growth) against at least one F. keratoplasticum strain. There
were also more extracts that either strongly or moderately inhibit the two environmental F.
keratoplasticum strains, FSSC-2i and FSSC-2g, in comparison to FSSC-2d, phylogenetically
related but environmentally unrelated fungus, potentially due to the fact that constant exposure of
ANG and JC bacteria to F. keratoplasticum results in the production of compounds to prevent
fungal fouling. The potent antifungal activity of the ANG and JC bacterial extracts suggest this
may be a promising source for discovery and development of novel antifungal compounds.
Comparative metabolomics was utilized to compare the chemical profiles of the challenged
clutch extract and control clutch extract, revealing two clusters of compounds only produced in
the egg clutches challenged with the fungus. Further investigation of these two clusters resulted in
putative identification of mycinamicin-like and glycerophosphocholine metabolites. Pure
standards and related compounds were tested in the 96-well antifungal assay with PC 18:1/0:0
(analogue of lyso-PAF) demonstrating the most potent activity possibly due to the unsaturation in
the fatty acid tail resulting in more effective penetration of the fungal cell membrane. In addition,
authenticated standards of mycinamicin IV and VI exhibited weak antifungal activity against F.
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keratoplasticum FSSC-2g, although confirmation of their presence in the clutch was not
conclusive.
In chapter 4, to further understand the function of the ANG and JC bacteria, comparative
metabolomics, biological assays, and experimentally driven microbial interactions were integrated
to identify defensive secondary metabolites. A molecular network was generated using ANG/JC
bacterial extracts demonstrating potent antifungal activity against at least one Fusarium
keratoplasticum strain, bacterial extracts inactive against all three Fusarium keratoplasticum
strains, challenged clutches, and control clutches. The molecular network prioritized seven
features produced by both the challenged clutches and active bacterial extracts and three features
produced by both the control clutch extract and active extracts for further analyses. Lincomycin B
was found to be present in both the control clutches and an active bacterial extract, Labrenzia sp.
ANG18. Whole genome sequencing confirmed the presence of lincomycin biosynthesis genes,
strengthening the evidence that Labrenzia sp. ANG18 is able to produce lincomycin B.
Labrenzia sp. ANG18 was pursued for isolation and identification of additional secondary
metabolites due to the potent and selective activity of the extract against F. keratoplasticum. Using
a suite of NMR analyses, a proposed peptide consisting of a tyrosine-valine moiety has been
partially elucidated. Future research will include final structure elucidation of the isolated
compound and testing the compound in the antimicrobial assays. In addition, techniques such as
systematic synthetic modifications or in silico programs can be utilized to explore structureactivity relationships of the most promising lead compounds, as well as work toward determining
their mode(s) of action. Additionally, further investigation of other bioactive ANG and JC bacterial
extracts is ongoing.
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Within the molecular network there were numerous metabolites that have yet to be
explored. Most importantly, from 10 mass spectral features of interest there were seven features
that have yet to be identified from both the challenged clutches and active bacterial extracts.
Moreover, there are still two features present in both the control clutches and active extracts that
still need to be characterized. Future studies should include comparing the masses of the seven
compounds to additional natural product databases to determine if the compound is known.
Labrenzia sp. ANG18 may not be the only bacteria responsible for the production of
antifungal metabolites. Due to the promising antifungal activity of several ANG and JC bacterial
extracts against three phylogenetically related F. keratoplasticum strains and C. albicans, studies
are ongoing to continue screening ANG/JC bacterial extracts against several human fungal
pathogens including Candida glabrata (wild type), C. glabrata (fluconazole resistant), and C.
auris (an emergent and particularly infectious fungal strain). In addition, all ANG and JC bacterial
extracts will be screened against human bacterial pathogens including but not limited to Bacillus
subtilis, methicillin-sensitive Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), and
Pseudomonas aeruginosa.
In addition to the antimicrobial activity of the ANG and JC bacterial extracts highlighted
in this dissertation, six ANG bacterial isolates that all have been identified as Leisingera sp.
(ANG1, DT, S, M6, S3, S5, M7) demonstrate differential biological activity but share high
sequence homology (>98% average nucleotide identity). Consequently, an interesting avenue of
research could be comparing the chemical compounds produced by these six highly homologous
Leisingera strains, using molecular networking to further understand their differential biological
activity.
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Future research should include investigating other classes of bacteria that are less
represented in the ANG such as Verrucomicrobia and Flavobacteria for antimicrobial secondary
metabolites as well as continuing to analyze Proteobacteria. Some of the ANG and JC bacteria
may be difficult to culture under laboratory conditions and/or only produce defensive secondary
metabolites through interactions with additional members of the JC bacterial community.
Therefore, synergistic studies testing one or more ANG and JC bacterial extracts in the biological
assays or co-culturing the ANG and JC bacterial isolates with F. keratoplasticum could lead to
identification of promising novel compounds.
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Appendix A: Supplemental Data for Chapter II Bacterial Symbiont, Leisingera sp. JC1,
Associated with the Hawaiian Bobtail Squid Produces Indigoidine
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Table A1. Leisingera sp. JC1 indigoidine biosynthesis operon is highly similar to Leisingera
sp. Y4I. The JC1 biosynthesis operon was compared to additional bacterial strains that produce
indigoidine. [Dr. Andrea Suria obtained all of the data and prepared this table.]

Gene

igiE
igiF
igiD
igiC
igiB
igiR

Annotation

Cyanate transport
protein, CynX
4-oxalocrotonate
tautomerase
Peptide synthetase
Arylmalonate
decarboxylase
Hydroxyisobutyrate
dehydrogenase
Transcriptional
regulator, TetR

% Amino acid
identity to
Leisingera sp.
Y4I operon

% Amino acid
identity to
Vogesella
indigofera
operon

% Amino acid
identity to
Streptomyces
lavendulae
operon

% Amino acid
identity to
Dickeya
dadantii 3937
operon

95

58

NA

NA

91

NA*

NA

NA

91

53

50

49

95

56

NA

NA

93

51

NA

NA

90

42

NA

NA

*NA, not applicable, no homolog of the gene present in that organism
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Figure A1. Leisingera sp. JC1 biosynthetic gene clusters share high similarity to Leisingera
sp. Y4I biosynthetic gene clusters. [Dr. Andrea Suria obtained all of the data and prepared this
figure.]
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Appendix B: Supplemental Data for Chapter III: Bacteria Associated with the Hawaiian
Bobtail Squid Protect Eggs from Fungal Fouling
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Figure B1. Treatment of eggs with an antibiotic cocktail and subsequent development of a
fungal biofilm significantly reduced hatch of juveniles. Eggs were treated with 25 µg/mL of an
antibiotic cocktail (t4=3.572, p=0.023). Hatching levels were unaffected when eggs were treated
with the antibiotic cocktail and maintained in a laminar flow hood (t2=1.289, p=0.326) or under
low temperatures (15-20 °C, t3=0.738, p=0.514) to prevent fungal growth. The antibiotic cocktail
included penicillin G, kanamycin, spectinomycin, streptomycin, and gentamicin, each at a
concentration of 25 µg/mL. Data point shape reflects eggs taken from the same initial clutch.
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Table B1. Percentages of F. keratoplasticum spp. (FSSC-2i, FSSC-2g, and FSSC-2d) and
Candida albicans wild type (Ca) fungal growth from the 96-well liquid antifungal assay.
ANG/JC Isolate

Percent Fungal Growth
FSSC-2i
FSSC-2g
FSSC-2d
104.3±5.3
106.8±14.9 116.3±14.5
42.8±1.1
68.0±1.6
49.4±2.5
33.1±8.2
42.8±8.7
52.2±2.8
14.8±14.8
48.4±3.2
81.2±4.8
108.3±8.3
109.3±5.6 134.0±4.3
64.0±9.5
99.6±7.5
94.6±11.1
53.5±5.9
45.9±4.8
56.4±2.5
71.4±6.8
79.5±11.4 76.0±5.3
29.1±2.5
43.6±8.1
64.9±14.5
83.3±3.2
87.4±4.8
97.9±13.3
29.8±3.1
66.3±7.7
58.6±0.6
61.0±6.5
66.8±6.4
67.5±10.7
101.2±8.4
89.7±9.6
121.8±10.9
90.7±7.1
84.3±5.6
91.5±6.2
-11.7±9.3
16.8±15.0 29.6±15.4
118.7±11.6 138.5±5.5 122.0±11.7
65.8±13.7
66.4±8.8
53.4±8.0
96.5±5.7
97.2±1.5
88.5±12.1
98.8±12.3
106.5±4.1 115.5±1.2
104.7±5.4
117.8±10.1 104.9±8.9
8.6±13.7
-15.1±29.0 16.6±13.2
75.5±0.5
74.6±6.5
89.9±0.1
62.9±5.6
41.1±12.1 55.3±10.4
-150.9±22.7 -230.0±3.7 -109.6±14.7
118.2±2.6
55.9±3.4
34.1±1.4
134.3±8.3
125.1±8.8 134.7±14.7
-23.3±13.2 -60.9±18.8 -18.9±13.9
12.7±14.8
13.7±21.2 18.4±8.8
-89.6±3.2
55.5±8.0
53.3±14.6

Gamma.

Alphaproteobacteria

Ca
Leisingera sp. ANG1
36.7±5.5
Leisingera sp. ANG13
141.2±10.2
Leisingera sp. ANG14
132.9±1.5
Leisingera sp. ANG15
158.9±6.1
Leisingera sp. ANG-DT
136.7±1.3
Leisingera sp. JC1
33.3±9.8
Leisingera sp. JC11
22.5±3.9
Leisingera sp. JC57
116.3±8.9
Leisingera sp. JC61
61.2±18.9
Leisingera sp. ANG-M1
153.4±3.0
Leisingera sp. ANG-M4
142.0±15.0
Leisingera sp. ANG-M6
31.2±7.8
Leisingera sp. ANG-M7
31.4±7.4
Leisingera sp. ANG-S
152.0±5.1
Leisingera sp. ANG-S2
24.2±7.0
Leisingera sp. ANG-S3
183.8±0.2
Leisingera sp. ANG-S5
112.0±2.7
Leisingera sp. ANG-VP
144.7±9.9
Nautella sp. ANG-M5
165.1±10.7
Ruegeria sp. ANG6
137.3±12.2
Ruegeria sp. ANG10
122.2±3.6
Ruegeria sp. ANG17
102.7±1.8
Ruegeria sp. JC13
146.3±10.2
Ruegeria sp. ANG-R
110.0±10.5
Ruegeria sp. ANG-S4
168.7±3.3
Tateyamaria sp. ANG-S1
163.9±0.2
Labrenzia sp. ANG18
42.4±14.3
Alteromonas sp. JC21
164.3±5.3
Pseudoalteromonas sp.
24.7±7.4
JC22
Pseudoalteromonas sp.
42.3±0.5
39.3±8.1
62.6±9.5
19.8±4.2
JC28
Vibrio sp. JC34
7.8±10.8
4.9±11.1
16.4±7.6
116.7±3.7
Muricauda sp. ANG21
36.5±11.7
78.8±5.9
89.0±8.4
24.3±3.0
Flavo.
Tenacibaculum sp. JC62
116.3±0.7
96.0±6.4
123.9±1.4
127.0±6.0
Amp B (Pos. control)
9.7±4.2
0.3±0.3
2.5±1.4
2.0±0.4
Controls
DMSO (Neg. control)
100±0.0
100±0.0
100±0.0
100±0.0
Percentages are an average of at least 2 biological replicates performed in technical triplicate ± the
standard error of the mean. Gamma. (Gammaproteobacteria), Flavo. (Flavobacteriia).
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Experimental

Antibiotic Clutch Experiments
Adult female Euprymna scolopes were collected from a protected sandflat in Maunlua
Bay, Oahu, HI (21°26'3.36" N, 157°47'20.78" W) and were shipped to the University of
Connecticut to be maintained in aquaria. Egg clutches laid in captivity by these squid were split
into similarly sized groups and placed in aerated filter-sterilized artificial seawater (FSSW). Clutch
segments were treated with either an antibiotic cocktail (25 µg/mL each of penicillin G,
kanamycin, spectinomycin, streptomycin, and gentamicin) or 25 µg/mL chloramphenicol, and
were monitored over a four-week period with daily water changes and fresh antibiotics. The
viability of each clutch group was determined once hatching was complete (two days without
additional juveniles produced) by dividing the number of unhatched eggs by the number of total
eggs (number of unhatched eggs added to the number of juveniles produced). Health of a subset
of hatched juveniles was checked by inoculating the water with the light organ symbiont, Vibrio
fischeri, and determining whether colonization occurred. Percent hatch was compared between
untreated and antibiotic-treated clutches using a paired two-tailed t-test.

Fungal Isolation and Characterization
Fusarium keratoplasticum FSSC-2g (12-1807) was isolated from an egg clutch treated
with chloramphenicol as described above. During culturing experiments with F. keratoplasticum
FSSC-2g we did not observe growth or germination at temperatures between 15-20 °C on SWT
media.
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F. keratoplasticum FSSC-2i (66667) was isolated from a clutch deposited by a wild female
while maintained in a tank with natural Hawaiian seawater and Hawaiian sand at Kewalo Marine
Laboratory, Oahu, HI. The clutch was divided into two groups, one was untreated and the other
treated with 25 µg/mL of antibiotic cocktail for one week while in an aerated beaker with daily
water changes. After one week both groups were transferred back to their original tank with
running seawater for the remainder of embryogenesis. The untreated group had 94% viability,
while the antibiotic-treated section had 10% clutch viability and developed a biofilm. The outer
capsule of an egg that did not hatch and a decapsulated egg containing a viable embryo from the
antibiotic-treated section were both plated onto seawater tryptone (SWT) to ensure sampling of
diverse fungi.
Both fungal cultures were further isolated on inhibitory mold agar with 0.05 g/L
gentamicin. Initial identification of fungal isolates occurred by analysis of morphologic
characteristics on carnation leaf agar and DNA sequence analysis of the ITS-1 region of rRNA.
PCR

was

performed

using

two

general

fungal

ITS-1

primers

(ITS-5,

5'-

GGAAGTAAAAGTCGTAACAAGG-3'; ITS-2, 5'-GGAAGTAAAAGTCGTAACAAGG-3', 41)
and GoTaq polymerase (Promega, Madison, WI) with the following profile conditions: initial
denaturation for 3 min at 95 °C; 30 cycles of denaturation for 30 sec at 95 °C, annealing for 30 sec
at 62 °C, and elongation for 1 min at 72 °C. PCR products were sequenced in both directions and
identified

as

F.

keratoplasticum

via

databases

BLASTn

analysis

at

NCBI

(http://www.ncbi.nlm.nih.gov/BLAST/) and RDP (http://rdp.cme.msu.edu/seqmatch).
Portions of three loci (TEF1, RPB2, ITS + LSU rDNA) were used to precisely identify the
three Fusarium strains used in the present study as F. keratoplasticum following a published
protocol (2). Arabic numerals and lowercase roman letters, respectively, identify species and
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unique 3-locus haplotypes (Figure S3). Maximum parsimony (MP) and maximum likelihood (ML)
phylogenetic analyses were conducted, respectively, with PAUP* 4.0b10 (3) and GARLI 2.01 (4).
MP analyses were conducted using the heuristic search option, the tree bisection–reconnection
(TBR) branch-swapping algorithm with MULPARS on and 1000 random sequence addition
replicates. The CIPRES Science Gateway TeraGrid (https://www.phylo.org/) (5) was used to
conduct the ML analysis employing the GTR + I + Γ model of molecular evolution. Clade support
was assessed by 1000 MP and ML bootstrap pseudoreplicates of the data.

Egg Component Experiments
A method developed for harvesting conidia of Fusarium oxysporum (6) was modified for
use with F. keratoplasticum. Fusarium keratoplasticum FSSC-2g was grown on a rotary shaker
for 3-5 days in SWT at 30 °C. The culture was then strained through sterile gauze and centrifuged
for 10 min at 3,200 x g. Conidia were then rinsed twice with sterile water and re-pelleted after each
wash, after which they were resuspended in sterile water. Conidia were quantified using a
hemocytometer and correlated with OD530 to determine a conversion factor of 3x106 bud
cells/mL/OD530. Refrigeration for up to one week was found to have no effect on conidial viability.
E. scolopes eggs from one clutch were dissected using sterile forceps into their various
components: intact eggs, eggs lacking outer capsule, and eggs lacking outer capsule and jelly coat
(n=4 trials, 8-10 eggs/treatment). Dissections were completed at day 5 of embryogenesis, as earlier
dissection prevented embryo development. These components were challenged with 104/mL of F.
keratoplasticum conidia over the course of embryogenesis, which is approximately an order of
magnitude higher than the eggs were likely to encounter naturally. Eggs were maintained in FSSW
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with water changes and fresh conidia were added every 2-3 days. They were maintained on a
rocker to provide aeration.

Transmission Electron Microscopy
A freshly deposited E. scolopes clutch was divided into three groups. One group was
untreated, one group was treated with 20 µg/mL of the antibiotic chloramphenicol, and one was
exposed only to 0.13 µl/mL of 95% ethanol, the solvent for chloramphenicol. Each group was
maintained in aerated FSSW, which was changed daily. By day 21 a thick fungal biofilm had
formed on the antibiotic-treated eggs. Decapsulated eggs were prepared for TEM following
established protocols. No fungal spores or hyphae were observed in the ethanol alone-treated eggs.

Antibiotic-treatment Effects on Bacterial Communities
Antibiotic-treated (chloramphenicol or antibiotic cocktail as described above) clutch
segments were maintained in a laminar flow hood to prevent infection and were otherwise treated
as those described above. Throughout the course of experiments five eggs from the same clutch
(n=3 replicates) were sampled on days 0, 10, and 21; the JC was isolated by dissection. JCs were
surface sterilized in ethanol, homogenized in filter-sterilized squid Ringer’s solution [FSSR,], then
plated on SWT to quantify culturable JC bacterial abundance. Differences in bacterial load
between antibiotic-treated JCs and untreated JCs were analyzed via two-tailed t-tests for each time
point.
Biofilms that formed on clutches treated with antibiotics above were homogenized in FSSR
(n=12) and biofilm bacterial DNA was extracted using the DNeasy Blood and Tissue kit according
to the manufacturer’s protocol (Qiagen, Valencia, CA). DNA concentration was determined using
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the Qubit® dsDNA High Sensitivity assay (ThermoFisher Scientific Inc., Waltham, MA) and
averaged 1.13 ± 0.79 ng/μl. The V4 region of the 16S rRNA gene was sequenced on an Illumina
MiSeq (Illumina, San Diego, CA, USA) following established protocols. Sequence data were
analyzed using QIIME (12) and NMDS plots of Bray Curtis beta-diversity analyses that were
created in R using the VEGAN package as previously described. Sequence data were compared to
ANG/JC community data previously published under the project ID ENA PRJEB14655, accession
numbers ERS1498392 to ERS1498398, ERS1496666 to ERS1496676, and ERS1496678 to
ERS1496722. Biofilm sequences were deposited in the European Nucleotide Archive (ENA)
under the project ID PRJEB23346.
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